propanal - Ontology Report - Rat Genome Database

Submit Data | Help | Video Tutorials | News | Publications | Download | REST API | Citing RGD | Contact

Advanced Search (OLGA)

CHEBI ONTOLOGY - ANNOTATIONS

{{ watchLinkText }}

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.

Term:	propanal	go back to main search page
Accession:	CHEBI:17153	browse the term
Definition:	An aldehyde that consists of ethane bearing a formyl substituent. The parent of the class of propanals.
Synonyms:	related_synonym:	1-Propanal; Aldehyde propionique; C2H5CHO; Formula=C3H6O; InChI=1S/C3H6O/c1-2-3-4/h3H,2H2,1H3; InChIKey=NBBJYMSMWIIQGU-UHFFFAOYSA-N; Methylacetaldehyde; Propaldehyde; Propanaldehyde; Propional; Propionaldehyde; Propionic aldehyde; Propyl aldehyde; Propylaldehyde; Propylic aldehyde; SMILES=[H]C(=O)CC; n-Propanal; n-Propionaldehyde
	alt_id:	CHEBI:14898; CHEBI:26281; CHEBI:41359; CHEBI:45052; CHEBI:8468
	xref:	CAS:123-38-6; HMDB:HMDB0003366; KEGG:C00479
	xref_mesh:	MESH:C005556
	xref:	MetaCyc:CPD-665; PDBeChem:CBG; PMID:20097366; PMID:21568340; Reaxys:506010; UM-BBD_compID:c0207; Wikipedia:Propanal

show annotations for term's descendants Sort by:
Rat (1747) Mouse (1772) Human (2039) Chinchilla (0) Bonobo (0) Dog (0) Squirrel (0) Pig (0) Green Monkey (0) Naked Mole-rat (0) All
Genes (1772)

propanal

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

RIKEN cDNA 1700012B09 gene

decreases expression

propionaldehyde results in decreased expression of C11ORF97 mRNA

NCBI chr 9:14,667,888...14,682,345
Ensembl chr 9:14,667,883...14,682,326

G

RIKEN cDNA 2310057J18 gene

increases expression

propionaldehyde results in increased expression of C6ORF58 mRNA

NCBI chr10:28,848,284...28,862,302
Ensembl chr10:28,848,284...28,862,299

G

RIKEN cDNA 2900092C05 gene

increases expression

propionaldehyde results in increased expression of C19ORF18 mRNA

NCBI chr 7:12,246,391...12,290,250
Ensembl chr 7:12,246,444...12,290,250

G

RIKEN cDNA 4921504E06 gene

increases expression

propionaldehyde results in increased expression of C10ORF67 mRNA

NCBI chr 2:19,467,648...19,558,721
Ensembl chr 2:19,467,648...19,558,725

G

RIKEN cDNA 4930444P10 gene

increases expression

propionaldehyde results in increased expression of C8ORF89 mRNA

NCBI chr 1:16,136,198...16,163,549
Ensembl chr 1:16,136,203...16,163,549

G

RIKEN cDNA 4930562C15 gene

decreases expression

propionaldehyde results in decreased expression of C16ORF96 mRNA

NCBI chr16:4,653,280...4,685,555
Ensembl chr16:4,653,280...4,685,550

G

RIKEN cDNA 4933405L10 gene

decreases expression

propionaldehyde results in decreased expression of C16ORF86 mRNA

NCBI chr 8:106,434,921...106,436,877
Ensembl chr 8:106,434,287...106,436,878

G

RIKEN cDNA 4933430I17 gene

increases expression

propionaldehyde results in increased expression of C9ORF43 mRNA

NCBI chr 4:62,443,541...62,471,270
Ensembl chr 4:62,443,606...62,466,230

G

RIKEN cDNA 9030622O22 gene

decreases expression

propionaldehyde results in decreased expression of LINC00261 mRNA

NCBI chr 2:147,786,383...147,882,123
Ensembl chr 2:147,785,944...147,882,569

G

RIKEN cDNA 9130008F23 gene

increases expression

propionaldehyde results in increased expression of C6ORF141 mRNA

NCBI chr17:41,186,373...41,191,449
Ensembl chr17:41,186,373...41,191,450

G

RIKEN cDNA 9530057J20 gene

increases expression

propionaldehyde results in increased expression of POTEM mRNA

NCBI chr 8:20,478,979...20,510,931
Ensembl chr 8:20,478,993...20,501,314

G

alpha-1-B glycoprotein

increases expression

propionaldehyde results in increased expression of A1BG mRNA

NCBI chr15:60,789,438...60,793,119
Ensembl chr15:60,768,708...60,794,861

G

alpha-2-macroglobulin

increases expression

propionaldehyde results in increased expression of A2M mRNA

NCBI chr 6:121,612,920...121,656,197
Ensembl chr 6:121,612,335...121,656,186

G

RIKEN cDNA A930018P22 gene

increases expression

propionaldehyde results in increased expression of C11ORF91 mRNA

NCBI chr 2:103,953,114...103,955,091
Ensembl chr 2:103,953,114...103,955,094

G

expressed sequence AA467197

increases expression

propionaldehyde results in increased expression of C15ORF48 mRNA

NCBI chr 2:122,479,807...122,482,996
Ensembl chr 2:122,478,906...122,483,111

G

expressed sequence AA986860

increases expression

propionaldehyde results in increased expression of C1ORF116 mRNA

NCBI chr 1:130,659,707...130,672,359
Ensembl chr 1:130,659,713...130,672,359

G

arylalkylamine N-acetyltransferase

decreases expression

propionaldehyde results in decreased expression of AANAT mRNA

NCBI chr11:116,482,547...116,489,022
Ensembl chr11:116,477,258...116,488,506

G

aminoadipate-semialdehyde synthase

increases expression

propionaldehyde results in increased expression of AASS mRNA

NCBI chr 6:23,072,172...23,132,985
Ensembl chr 6:23,072,172...23,132,985

G

4-aminobutyrate aminotransferase

increases expression

propionaldehyde results in increased expression of ABAT mRNA

NCBI chr16:8,331,293...8,439,432
Ensembl chr16:8,331,293...8,439,432

G

ATP-binding cassette, sub-family A member 1

increases expression

propionaldehyde results in increased expression of ABCA1 mRNA

NCBI chr 4:53,030,789...53,159,988
Ensembl chr 4:53,030,787...53,159,895

G

ATP-binding cassette, sub-family A member 4

increases expression

propionaldehyde results in increased expression of ABCA4 mRNA

NCBI chr 3:121,837,547...121,973,719
Ensembl chr 3:121,838,092...121,973,772

G

ATP-binding cassette, sub-family B member 5

increases expression

propionaldehyde results in increased expression of ABCB5 mRNA

NCBI chr12:118,831,221...118,930,169
Ensembl chr12:118,831,559...118,930,156

G

ATP-binding cassette, sub-family C member 3

decreases expression

propionaldehyde results in decreased expression of ABCC3 mRNA

NCBI chr11:94,234,121...94,283,843
Ensembl chr11:94,234,121...94,283,823

G

ATP-binding cassette, sub-family C member 6

decreases expression

propionaldehyde results in decreased expression of ABCC6 mRNA

NCBI chr 7:45,625,804...45,679,915
Ensembl chr 7:45,616,979...45,679,726

G

ATP binding cassette subfamily G member 4

increases expression

propionaldehyde results in increased expression of ABCG4 mRNA

NCBI chr 9:44,184,485...44,199,953
Ensembl chr 9:44,184,485...44,199,912

G

ATP binding cassette subfamily G member 5

decreases expression

propionaldehyde results in decreased expression of ABCG5 mRNA

NCBI chr17:84,965,602...84,990,439
Ensembl chr17:84,965,662...84,990,439

G

abhydrolase domain containing 8

increases expression

propionaldehyde results in increased expression of ABHD8 mRNA

NCBI chr 8:71,909,344...71,917,351
Ensembl chr 8:71,909,349...71,916,299

G

actin binding LIM protein family, member 3

increases expression

propionaldehyde results in increased expression of ABLIM3 mRNA

NCBI chr18:61,932,463...62,044,956
Ensembl chr18:61,932,463...62,044,895

G

amino carboxymuconate semialdehyde decarboxylase

decreases expression

propionaldehyde results in decreased expression of ACMSD mRNA

NCBI chr 1:127,657,149...127,695,723
Ensembl chr 1:127,657,150...127,695,715

G

acyl-CoA thioesterase 4

increases expression

propionaldehyde results in increased expression of ACOT4 mRNA

NCBI chr12:84,084,028...84,091,497
Ensembl chr12:84,085,153...84,095,375

G

acyl-CoA thioesterase 9

increases methylation

propionaldehyde results in increased methylation of ACOT9 gene

NCBI chr X:154,045,439...154,080,650
Ensembl chr X:154,045,439...154,080,650

G

acrosomal vesicle protein 1

decreases expression

propionaldehyde results in decreased expression of ACRV1 mRNA

NCBI chr 9:36,604,550...36,610,139
Ensembl chr 9:36,604,516...36,610,139

G

actin alpha 1, skeletal muscle

increases expression

propionaldehyde results in increased expression of ACTA1 mRNA

NCBI chr 8:124,618,497...124,621,514
Ensembl chr 8:124,618,508...124,621,490

G

actin alpha 2, smooth muscle, aorta

increases expression

propionaldehyde results in increased expression of ACTA2 mRNA

NCBI chr19:34,217,736...34,232,985
Ensembl chr19:34,218,490...34,232,990

G

activin A receptor, type II-like 1

increases expression

propionaldehyde results in increased expression of ACVRL1 mRNA

NCBI chr15:101,026,403...101,043,217
Ensembl chr15:101,026,403...101,043,217

G

a disintegrin and metallopeptidase domain 11

increases expression

propionaldehyde results in increased expression of ADAM11 mRNA

NCBI chr11:102,652,261...102,671,089
Ensembl chr11:102,652,265...102,671,088

G

ADAM metallopeptidase domain 19

increases expression

propionaldehyde results in increased expression of ADAM19 mRNA

NCBI chr11:45,945,329...46,038,174
Ensembl chr11:45,946,819...46,038,170

G

a disintegrin and metallopeptidase domain 21

increases expression

propionaldehyde results in increased expression of ADAM21 mRNA

NCBI chr12:81,605,349...81,615,248
Ensembl chr12:81,605,358...81,615,248

G

a disintegrin and metallopeptidase domain 33

decreases expression

propionaldehyde results in decreased expression of ADAM33 mRNA

NCBI chr 2:130,892,739...130,905,734
Ensembl chr 2:130,892,511...130,905,734

G

ADAM metallopeptidase with thrombospondin type 1 motif 10

decreases expression

propionaldehyde results in decreased expression of ADAMTS10 mRNA

NCBI chr17:33,742,620...33,772,756
Ensembl chr17:33,743,178...33,772,756

G

ADAM metallopeptidase with thrombospondin type 1 motif 14

increases expression

propionaldehyde results in increased expression of ADAMTS14 mRNA

NCBI chr10:61,032,886...61,109,447
Ensembl chr10:61,032,891...61,109,217

G

ADAM metallopeptidase with thrombospondin type 1 motif 17

decreases expression

propionaldehyde results in decreased expression of ADAMTS17 mRNA

NCBI chr 7:66,487,387...66,802,373
Ensembl chr 7:66,489,483...66,802,919

G

ADAM metallopeptidase with thrombospondin type 1 motif 19

decreases expression

propionaldehyde results in decreased expression of ADAMTS19 mRNA

NCBI chr18:58,967,819...59,186,754
Ensembl chr18:58,969,739...59,187,132

G

ADAM metallopeptidase with thrombospondin type 1 motif 4

increases expression

propionaldehyde results in increased expression of ADAMTS4 mRNA

NCBI chr 1:171,077,698...171,089,836
Ensembl chr 1:171,077,990...171,088,206

G

ADAM metallopeptidase with thrombospondin type 1 motif 6

increases expression

propionaldehyde results in increased expression of ADAMTS6 mRNA

NCBI chr13:104,423,026...104,633,203
Ensembl chr13:104,424,343...104,633,203

G

ADAMTS-like 3

decreases expression

propionaldehyde results in decreased expression of ADAMTSL3 mRNA

NCBI chr 7:81,984,612...82,263,658
Ensembl chr 7:81,984,902...82,263,658

G

ADAMTS-like 4

increases expression

propionaldehyde results in increased expression of ADAMTSL4 mRNA

NCBI chr 3:95,583,511...95,595,232
Ensembl chr 3:95,583,511...95,595,228

G

ArfGAP with dual PH domains 2

increases expression

propionaldehyde results in increased expression of ADAP2 mRNA

NCBI chr11:80,044,869...80,071,449
Ensembl chr11:80,044,931...80,069,784

G

adhesion G protein-coupled receptor A2

increases expression

propionaldehyde results in increased expression of ADGRA2 mRNA

NCBI chr 8:27,575,546...27,613,464
Ensembl chr 8:27,575,611...27,613,464

G

adhesion G protein-coupled receptor B1

increases expression

propionaldehyde results in increased expression of ADGRB1 mRNA

NCBI chr15:74,388,045...74,461,314
Ensembl chr15:74,388,044...74,461,314

G

adhesion G protein-coupled receptor E1

increases expression

propionaldehyde results in increased expression of ADGRE1 mRNA

NCBI chr17:57,665,650...57,790,527
Ensembl chr17:57,665,691...57,790,527

G

adhesion G protein-coupled receptor F4

increases expression

propionaldehyde results in increased expression of ADGRF4 mRNA

NCBI chr17:42,967,099...43,008,460
Ensembl chr17:42,967,782...43,003,175

G

adhesion G protein-coupled receptor V1

increases expression

propionaldehyde results in increased expression of ADGRV1 mRNA

NCBI chr13:81,243,187...81,781,504
Ensembl chr13:81,243,187...81,781,273

G

alcohol dehydrogenase 1 (class I)

decreases expression

propionaldehyde results in decreased expression of ADH1C mRNA

NCBI chr 3:137,983,346...137,996,459
Ensembl chr 3:137,966,752...137,996,459

G

alcohol dehydrogenase 6B (class V)

decreases expression

propionaldehyde results in decreased expression of ADH6 mRNA

NCBI chr 3:138,047,176...138,064,621
Ensembl chr 3:138,047,536...138,064,622

G

adenosine A2a receptor

increases expression

propionaldehyde results in increased expression of ADORA2A mRNA

NCBI chr10:75,152,711...75,170,626
Ensembl chr10:75,152,711...75,170,618

G

adrenergic receptor, beta 1

increases expression

propionaldehyde results in increased expression of ADRB1 mRNA

NCBI chr19:56,710,549...56,713,582
Ensembl chr19:56,710,631...56,721,545

G

adrenergic receptor, beta 2

increases expression

propionaldehyde results in increased expression of ADRB2 mRNA

NCBI chr18:62,310,784...62,313,052
Ensembl chr18:62,310,887...62,313,030

G

androgen dependent TFPI regulating protein

increases expression

propionaldehyde results in increased expression of ADTRP mRNA

NCBI chr13:41,916,621...42,001,092
Ensembl chr13:41,916,624...42,001,160

G

actin filament associated protein 1-like 2

increases expression

propionaldehyde results in increased expression of AFAP1L2 mRNA

NCBI chr19:56,900,786...57,017,021
Ensembl chr19:56,900,793...56,996,660

G

AF4/FMR2 family, member 2

decreases expression

propionaldehyde results in decreased expression of AFF2 mRNA

NCBI chr X:68,403,796...68,915,660
Ensembl chr X:68,403,900...68,911,643

G

ArfGAP with GTPase domain, ankyrin repeat and PH domain 2

increases expression

propionaldehyde results in increased expression of AGAP2 mRNA

NCBI chr10:126,911,154...126,929,039
Ensembl chr10:126,911,153...126,929,038

G

advanced glycosylation end product-specific receptor

decreases expression

propionaldehyde results in decreased expression of AGER mRNA

NCBI chr17:34,816,545...34,819,911
Ensembl chr17:34,816,836...34,819,910

G

angiotensinogen

decreases expression

propionaldehyde results in decreased expression of AGT mRNA

NCBI chr 8:125,283,326...125,296,445
Ensembl chr 8:125,283,273...125,296,445

G

angiotensin II receptor, type 1a

decreases expression

propionaldehyde results in decreased expression of AGTR1 mRNA

NCBI chr13:30,520,339...30,566,850
Ensembl chr13:30,520,424...30,566,850

G

AHNAK nucleoprotein 2

increases expression

propionaldehyde results in increased expression of AHNAK2 mRNA

NCBI chr12:112,738,631...112,766,278
Ensembl chr12:112,738,628...112,766,277

G

aryl-hydrocarbon receptor repressor

increases expression

propionaldehyde results in increased expression of AHRR mRNA

NCBI chr13:74,359,237...74,440,450
Ensembl chr13:74,359,237...74,440,450

G

expressed sequence AI593442

decreases expression

propionaldehyde results in decreased expression of C11ORF87 mRNA

NCBI chr 9:52,584,332...52,593,434
Ensembl chr 9:52,584,342...52,591,080

G

allograft inflammatory factor 1-like

increases expression

propionaldehyde results in increased expression of AIF1L mRNA

NCBI chr 2:31,840,315...31,863,454
Ensembl chr 2:31,840,151...31,863,454

G

autoimmune regulator

increases methylation

propionaldehyde results in increased methylation of AIRE gene

NCBI chr10:77,865,856...77,879,444
Ensembl chr10:77,865,856...77,879,444

G

aldo-keto reductase family 1 member B

affects reduction
increases reduction

AKR1B1 protein affects the reduction of propionaldehyde analog
AKR1B1 protein results in increased reduction of propionaldehyde

PMID:9890881 PMID:11306073

NCBI chr 6:34,280,865...34,294,424
Ensembl chr 6:34,279,369...34,294,413

G

aldo-keto reductase family 1, member C6

decreases expression

propionaldehyde results in decreased expression of AKR1C4 mRNA

NCBI chr13:4,484,354...4,507,529
Ensembl chr13:4,484,305...4,507,876

G

aldehyde dehydrogenase family 1, subfamily A1

increases oxidation
multiple interactions
increases metabolic processing

ALDH1A1 protein results in increased oxidation of propionaldehyde
[ALDH1A1 protein binds to NAD] which results in increased oxidation of propionaldehyde; [ALDH1A1 protein co-treated with NAD] results in increased oxidation of propionaldehyde; [NAD co-treated with propionaldehyde] inhibits the reaction [Acrolein results in decreased activity of ALDH1A1 protein]; propionaldehyde inhibits the reaction [Acrolein results in decreased activity of ALDH1A1 protein]
ALDH1A1 protein results in increased metabolism of propionaldehyde

PMID:10559215 PMID:10856427 PMID:10998257 PMID:21256123 PMID:21349255 More...

NCBI chr19:20,469,947...20,620,827
Ensembl chr19:20,470,079...20,620,829

G

aldehyde dehydrogenase family 1, subfamily A3

increases expression

propionaldehyde results in increased expression of ALDH1A3 mRNA

NCBI chr 7:66,040,640...66,077,225
Ensembl chr 7:66,040,638...66,077,265

G

aldehyde dehydrogenase 1 family, member B1

multiple interactions

[ALDH1B1 protein co-treated with NAD] results in increased metabolism of propionaldehyde

NCBI chr 4:45,799,022...45,804,608
Ensembl chr 4:45,799,022...45,804,604

G

aldehyde dehydrogenase 1 family, member L1

decreases expression

propionaldehyde results in decreased expression of ALDH1L1 mRNA

NCBI chr 6:90,527,751...90,576,153
Ensembl chr 6:90,463,409...90,577,185

G

aldehyde dehydrogenase 2, mitochondrial

affects metabolic processing
increases oxidation
increases metabolic processing
multiple interactions

ALDH2 protein polymorphism affects the metabolism of propionaldehyde
ALDH2 protein results in increased oxidation of propionaldehyde
ALDH2 protein results in increased metabolism of propionaldehyde
daidzin inhibits the reaction [ALDH2 protein results in increased oxidation of propionaldehyde]; Magnesium promotes the reaction [ALDH2 protein results in increased oxidation of propionaldehyde]; molinate inhibits the reaction [ALDH2 protein results in increased metabolism of propionaldehyde]; molinate metabolite inhibits the reaction [ALDH2 protein results in increased metabolism of propionaldehyde]; molinate sulfoxide inhibits the reaction [ALDH2 protein results in increased metabolism of propionaldehyde]

PMID:11744614 PMID:20954713 PMID:21349255 PMID:23295226

NCBI chr 5:121,704,090...121,731,887
Ensembl chr 5:121,704,090...121,731,887

G

aldehyde dehydrogenase family 3, subfamily A1

increases metabolic processing

ALDH3A1 protein results in increased metabolism of propionaldehyde

PMID:19822198 PMID:21256123

NCBI chr11:61,099,336...61,109,244
Ensembl chr11:61,098,363...61,109,247

G

aldehyde dehydrogenase 3 family, member B1

decreases expression

propionaldehyde results in decreased expression of ALDH3B1 mRNA

NCBI chr19:3,963,491...3,980,898
Ensembl chr19:3,963,491...3,979,808

G

aldehyde dehydrogenase 4 family, member A1

increases expression

propionaldehyde results in increased expression of ALDH4A1 mRNA

NCBI chr 4:139,348,404...139,377,002
Ensembl chr 4:139,350,177...139,377,001

G

arachidonate 5-lipoxygenase

increases expression

propionaldehyde results in increased expression of ALOX5 mRNA

NCBI chr 6:116,387,030...116,438,139
Ensembl chr 6:116,387,038...116,438,139

G

arachidonate 5-lipoxygenase activating protein

increases expression

propionaldehyde results in increased expression of ALOX5AP mRNA

NCBI chr 5:149,201,814...149,224,963
Ensembl chr 5:149,201,577...149,224,963

G

alpha 1 microglobulin/bikunin precursor

decreases expression

propionaldehyde results in decreased expression of AMBP mRNA

NCBI chr 4:63,061,512...63,072,409
Ensembl chr 4:63,061,512...63,073,036

G

anti-Mullerian hormone type 2 receptor

increases expression

propionaldehyde results in increased expression of AMHR2 mRNA

NCBI chr15:102,353,437...102,363,075
Ensembl chr15:102,353,802...102,363,068

G

angiomotin-like 1

increases expression

propionaldehyde results in increased expression of AMOTL1 mRNA

NCBI chr 9:14,453,262...14,574,408
Ensembl chr 9:14,453,262...14,556,352

G

adenosine monophosphate deaminase 3

increases expression

propionaldehyde results in increased expression of AMPD3 mRNA

NCBI chr 7:110,367,291...110,411,612
Ensembl chr 7:110,367,413...110,411,612

G

amphiphysin

decreases expression

propionaldehyde results in decreased expression of AMPH mRNA

NCBI chr13:19,132,524...19,335,089
Ensembl chr13:19,132,375...19,335,091

G

angiopoietin 1

increases expression

propionaldehyde results in increased expression of ANGPT1 mRNA

NCBI chr15:42,288,063...42,540,373
Ensembl chr15:42,288,119...42,540,373

G

progressive ankylosis

decreases expression

propionaldehyde results in decreased expression of ANKH mRNA

NCBI chr15:27,466,763...27,594,995
Ensembl chr15:27,466,763...27,594,995

G

ankyrin repeat and death domain containing 1A

increases expression

propionaldehyde results in increased expression of ANKDD1A mRNA

NCBI chr 9:65,395,746...65,427,691
Ensembl chr 9:65,395,752...65,427,475

G

ankyrin repeat domain 1

increases expression

propionaldehyde results in increased expression of ANKRD1 mRNA

NCBI chr19:36,089,365...36,097,244
Ensembl chr19:36,089,361...36,097,499

G

ankyrin repeat domain 2

increases expression

propionaldehyde results in increased expression of ANKRD2 mRNA

NCBI chr19:42,024,358...42,033,550
Ensembl chr19:42,024,439...42,033,549

G

ankyrin repeat domain 29

increases expression

propionaldehyde results in increased expression of ANKRD29 mRNA

NCBI chr18:12,385,414...12,439,067
Ensembl chr18:12,385,419...12,438,854

G

ankyrin repeat domain 34A

increases expression

propionaldehyde results in increased expression of ANKRD34A mRNA

NCBI chr 3:96,503,599...96,507,442
Ensembl chr 3:96,503,952...96,507,091

G

ankyrin repeat domain 34B

increases expression

propionaldehyde results in increased expression of ANKRD34B mRNA

NCBI chr13:92,562,413...92,578,166
Ensembl chr13:92,562,404...92,578,166

G

ankyrin repeat domain 55

increases expression

propionaldehyde results in increased expression of ANKRD55 mRNA

NCBI chr13:112,424,985...112,523,391
Ensembl chr13:112,424,985...112,520,536

G

ankyrin repeat and sterile alpha motif domain containing 4B

decreases expression

propionaldehyde results in decreased expression of ANKS4B mRNA

NCBI chr 7:119,773,081...119,782,939
Ensembl chr 7:119,773,081...119,784,809

G

anillin, actin binding protein

decreases expression

propionaldehyde results in decreased expression of ANLN mRNA

NCBI chr 9:22,243,305...22,302,132
Ensembl chr 9:22,243,308...22,300,484

G

acidic nuclear phosphoprotein 32 family member B

decreases expression

propionaldehyde results in decreased expression of ANP32B mRNA

NCBI chr 4:46,450,926...46,472,657
Ensembl chr 4:46,450,902...46,472,657

G

acidic nuclear phosphoprotein 32 family member E

decreases expression

propionaldehyde results in decreased expression of ANP32E mRNA

NCBI chr 3:95,836,557...95,854,699
Ensembl chr 3:95,836,558...95,854,702

G

anthrax toxin receptor 1

increases expression

propionaldehyde results in increased expression of ANTXR1 mRNA

NCBI chr 6:87,110,835...87,312,757
Ensembl chr 6:87,110,835...87,312,803

G

anthrax toxin receptor 2

increases expression

propionaldehyde results in increased expression of ANTXR2 mRNA

NCBI chr 5:98,032,547...98,178,876
Ensembl chr 5:98,030,642...98,178,902

G

annexin A10

increases expression

propionaldehyde results in increased expression of ANXA10 mRNA

NCBI chr 8:62,510,076...62,576,227
Ensembl chr 8:62,510,076...62,576,184

G

annexin A11

decreases expression

propionaldehyde results in decreased expression of ANXA11 mRNA

NCBI chr14:25,842,575...25,887,228
Ensembl chr14:25,842,580...25,887,228

G

annexin A13

decreases expression

propionaldehyde results in decreased expression of ANXA13 mRNA

NCBI chr15:58,204,860...58,261,123
Ensembl chr15:58,204,867...58,261,093

G

annexin A6

increases expression

propionaldehyde results in increased expression of ANXA6 mRNA

NCBI chr11:54,869,779...54,924,297
Ensembl chr11:54,869,934...54,924,271

G

amine oxidase, copper containing 3

increases expression

propionaldehyde results in increased expression of AOC3 mRNA

NCBI chr11:101,221,432...101,230,256
Ensembl chr11:101,221,431...101,232,764

G

aldehyde oxidase 1

increases expression

propionaldehyde results in increased expression of AOX1 mRNA

NCBI chr 1:58,068,963...58,145,569
Ensembl chr 1:58,069,090...58,145,572

G

adaptor protein complex AP-1, mu 2 subunit

decreases expression

propionaldehyde results in decreased expression of AP1M2 mRNA

NCBI chr 9:21,206,753...21,223,617
Ensembl chr 9:21,205,571...21,223,633

G

adaptor protein complex AP-1, sigma 1

increases expression

propionaldehyde results in increased expression of AP1S1 mRNA

NCBI chr 5:137,063,852...137,074,917
Ensembl chr 5:137,063,847...137,074,989

G

adaptor-related protein complex AP-1, sigma 3

increases expression

propionaldehyde results in increased expression of AP1S3 mRNA

NCBI chr 1:79,584,593...79,649,736
Ensembl chr 1:79,584,593...79,649,689

G

apolipoprotein A-I

decreases expression

propionaldehyde results in decreased expression of APOA1 mRNA

NCBI chr 9:46,139,928...46,141,767
Ensembl chr 9:46,139,878...46,141,764

G

apolipoprotein B mRNA editing enzyme, catalytic polypeptide 3

increases expression

propionaldehyde results in increased expression of APOBEC3H mRNA

NCBI chr15:79,774,620...79,802,419
Ensembl chr15:79,775,860...79,800,107

G

apolipoprotein D

increases expression

propionaldehyde results in increased expression of APOD mRNA

NCBI chr16:31,115,010...31,133,626
Ensembl chr16:31,115,010...31,133,626

G

apolipoprotein E

increases expression

propionaldehyde results in increased expression of APOE mRNA

NCBI chr 7:19,430,169...19,434,326
Ensembl chr 7:19,430,034...19,433,113

G

apolipoprotein H

decreases expression

propionaldehyde results in decreased expression of APOH mRNA

NCBI chr11:108,286,123...108,305,222
Ensembl chr11:108,234,180...108,305,222

G

apolipoprotein L 6

decreases expression

propionaldehyde results in decreased expression of APOL6 mRNA

NCBI chr15:76,929,195...76,941,308
Ensembl chr15:76,928,929...76,941,306

G

apolipoprotein L 9a

decreases expression

propionaldehyde results in decreased expression of APOL4 mRNA

NCBI chr15:77,287,989...77,295,280
Ensembl chr15:77,287,989...77,295,335

G

apolipoprotein L domain containing 1

increases expression

propionaldehyde results in increased expression of APOLD1 mRNA

NCBI chr 6:134,958,964...134,963,799
Ensembl chr 6:134,958,681...134,963,799

G

aquaporin 3

decreases expression

propionaldehyde results in decreased expression of AQP3 mRNA

NCBI chr 4:41,092,724...41,098,183
Ensembl chr 4:41,092,722...41,098,183

G

activity regulated cytoskeletal-associated protein

increases expression

propionaldehyde results in increased expression of ARC mRNA

NCBI chr15:74,540,930...74,544,419
Ensembl chr15:74,540,932...74,544,419

G

amphiregulin

increases expression

propionaldehyde results in increased expression of AREG mRNA

NCBI chr 5:91,287,458...91,296,291
Ensembl chr 5:91,287,458...91,296,291

G

arginase type II

increases expression

propionaldehyde results in increased expression of ARG2 mRNA

NCBI chr12:79,177,562...79,203,075
Ensembl chr12:79,177,551...79,203,075

G

Rho GTPase activating protein 11A

decreases expression

propionaldehyde results in decreased expression of ARHGAP11A mRNA

NCBI chr 2:113,661,837...113,679,006
Ensembl chr 2:113,661,837...113,679,006

G

Rho GTPase activating protein 22

increases expression

propionaldehyde results in increased expression of ARHGAP22 mRNA

NCBI chr14:32,935,952...33,091,893
Ensembl chr14:32,935,983...33,091,891

G

Rho GTPase activating protein 25

increases expression

propionaldehyde results in increased expression of ARHGAP25 mRNA

NCBI chr 6:87,435,526...87,510,241
Ensembl chr 6:87,435,527...87,510,241

G

Rho, GDP dissociation inhibitor beta

increases expression

propionaldehyde results in increased expression of ARHGDIB mRNA

NCBI chr 6:136,900,653...136,918,895
Ensembl chr 6:136,900,653...136,918,897

G

Rho guanine nucleotide exchange factor 4

increases expression

propionaldehyde results in increased expression of ARHGEF4 mRNA

NCBI chr 1:34,717,263...34,851,819
Ensembl chr 1:34,717,269...34,852,390

G

ADP-ribosylation factor-like 14

increases expression

propionaldehyde results in increased expression of ARL14 mRNA

NCBI chr 3:69,129,752...69,130,951
Ensembl chr 3:69,129,752...69,130,951

G

ADP-ribosylation factor-like 4C

increases expression

propionaldehyde results in increased expression of ARL4C mRNA

NCBI chr 1:88,625,947...88,629,913
Ensembl chr 1:88,600,847...88,629,943

G

armadillo repeat containing 3

increases expression

propionaldehyde results in increased expression of ARMC3 mRNA

NCBI chr 2:19,203,676...19,315,054
Ensembl chr 2:19,204,113...19,315,052

G

armadillo-like helical domain containing 1

increases expression

propionaldehyde results in increased expression of ARMH1 mRNA

NCBI chr 4:117,070,523...117,109,329
Ensembl chr 4:117,070,531...117,109,322

G

armadillo-like helical domain containing 4

increases expression

propionaldehyde results in increased expression of ARMH4 mRNA

NCBI chr14:49,919,017...50,020,843
Ensembl chr14:49,913,409...50,020,840

G

arrestin, beta 1

decreases expression

propionaldehyde results in decreased expression of ARRB1 mRNA

NCBI chr 7:99,184,356...99,255,979
Ensembl chr 7:99,184,673...99,255,978

G

arylsulfatase G

increases expression

propionaldehyde results in increased expression of ARSG mRNA

NCBI chr11:109,364,159...109,464,156
Ensembl chr11:109,364,200...109,464,156

G

arylsulfatase i

increases expression

propionaldehyde results in increased expression of ARSI mRNA

NCBI chr18:61,045,063...61,051,633
Ensembl chr18:61,044,852...61,051,633

G

ADP-ribosyltransferase 2b

increases expression

propionaldehyde results in increased expression of TIGD7 mRNA

NCBI chr 7:101,224,936...101,234,790
Ensembl chr 7:101,226,177...101,234,807

G

ADP-ribosyltransferase 4

decreases expression

propionaldehyde results in decreased expression of ART4 mRNA

NCBI chr 6:136,825,449...136,834,598
Ensembl chr 6:136,825,449...136,834,731

G

armadillo repeat gene deleted in velocardiofacial syndrome

increases expression

propionaldehyde results in increased expression of ARVCF mRNA

NCBI chr16:18,166,046...18,225,826
Ensembl chr16:18,166,046...18,225,826

G

aristaless related homeobox

decreases expression

propionaldehyde results in decreased expression of ARX mRNA

NCBI chr X:92,330,113...92,341,963
Ensembl chr X:92,330,051...92,341,963

G

ankyrin repeat and SOCS box-containing 18

decreases expression

propionaldehyde results in decreased expression of ASB18 mRNA

NCBI chr 1:89,880,313...89,942,388
Ensembl chr 1:89,877,942...89,942,388

G

ankyrin repeat and SOCS box-containing 2

increases expression

propionaldehyde results in increased expression of ASB2 mRNA

NCBI chr12:103,287,401...103,322,260
Ensembl chr12:103,287,401...103,322,260

G

ankyrin repeat and SOCS box-containing 4

increases expression

propionaldehyde results in increased expression of ASB4 mRNA

NCBI chr 6:5,383,386...5,433,022
Ensembl chr 6:5,383,386...5,433,022

G

anti-silencing function 1B histone chaperone

decreases expression

propionaldehyde results in decreased expression of ASF1B mRNA

NCBI chr 8:84,682,323...84,696,824
Ensembl chr 8:84,682,136...84,696,826

G

asialoglycoprotein receptor 1

decreases expression

propionaldehyde results in decreased expression of ASGR1 mRNA

NCBI chr11:69,939,735...69,948,721
Ensembl chr11:69,944,911...69,948,720

G

asialoglycoprotein receptor 2

decreases expression

propionaldehyde results in decreased expression of ASGR2 mRNA

NCBI chr11:69,983,470...69,997,013
Ensembl chr11:69,983,470...69,997,013

G

acetylserotonin O-methyltransferase

increases expression

propionaldehyde results in increased expression of ASMT mRNA

NCBI chr X:169,106,379...169,111,787
Ensembl chr X:169,106,280...169,112,125

G

aspartate beta-hydroxylase domain containing 2

increases expression

propionaldehyde results in increased expression of ASPHD2 mRNA

NCBI chr 5:112,532,220...112,543,236
Ensembl chr 5:112,532,220...112,542,732

G

abnormal spindle microtubule assembly

decreases expression

propionaldehyde results in decreased expression of ASPM mRNA

NCBI chr 1:139,381,450...139,421,826
Ensembl chr 1:139,382,510...139,421,829

G

argininosuccinate synthetase 1

increases expression

propionaldehyde results in increased expression of ASS1 mRNA

NCBI chr 2:31,360,282...31,410,682
Ensembl chr 2:31,360,219...31,410,684

G

astrotactin 2

increases expression

propionaldehyde results in increased expression of ASTN2 mRNA

NCBI chr 4:65,299,040...66,322,774
Ensembl chr 4:65,299,040...66,322,848

G

ataxia, cerebellar, Cayman type

increases expression

propionaldehyde results in increased expression of ATCAY mRNA

NCBI chr10:81,040,338...81,067,037
Ensembl chr10:81,040,342...81,066,667

G

ATPase, Na+/K+ transporting, alpha 2 polypeptide

increases expression

propionaldehyde results in increased expression of ATP1A2 mRNA

NCBI chr 1:172,099,276...172,125,631
Ensembl chr 1:172,099,276...172,125,631

G

ATPase, Na+/K+ transporting, beta 2 polypeptide

increases expression

propionaldehyde results in increased expression of ATP1B2 mRNA

NCBI chr11:69,490,554...69,496,786
Ensembl chr11:69,490,562...69,496,768

G

ATPase, Ca++ transporting, ubiquitous

increases expression

propionaldehyde results in increased expression of ATP2A3 mRNA

NCBI chr11:72,851,995...72,883,869
Ensembl chr11:72,851,995...72,883,870

G

ATPase, H+/K+ exchanging, gastric, alpha polypeptide

increases expression

propionaldehyde results in increased expression of ATP4A mRNA

NCBI chr 7:30,411,634...30,424,959
Ensembl chr 7:30,411,634...30,424,959

G

ATPase, H+ transporting, lysosomal V0 subunit A4

increases expression

propionaldehyde results in increased expression of ATP6V0A4 mRNA

NCBI chr 6:38,025,418...38,101,521
Ensembl chr 6:38,025,418...38,101,521

G

ATPase, class I, type 8B, member 3

increases expression

propionaldehyde results in increased expression of ATP8B3 mRNA

NCBI chr10:80,355,418...80,374,987
Ensembl chr10:80,355,418...80,374,958

G

aurora kinase B

decreases expression

propionaldehyde results in decreased expression of AURKB mRNA

NCBI chr11:68,936,477...68,942,490
Ensembl chr11:68,936,473...68,942,490

G

UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4

decreases expression

propionaldehyde results in decreased expression of B3GALT4 mRNA

PMID:25014914 PMID:26079696

NCBI chr17:34,168,886...34,170,462
Ensembl chr17:34,168,883...34,170,462

G

UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6

decreases expression

propionaldehyde results in decreased expression of B3GNT6 mRNA

NCBI chr 7:97,841,622...97,848,682
Ensembl chr 7:97,841,624...97,848,688

G

bile acid-Coenzyme A: amino acid N-acyltransferase

decreases expression

propionaldehyde results in decreased expression of BAAT mRNA

NCBI chr 4:49,489,416...49,507,915
Ensembl chr 4:49,489,422...49,506,557

G

BAI1-associated protein 3

increases expression

propionaldehyde results in increased expression of BAIAP3 mRNA

NCBI chr17:25,461,633...25,475,255
Ensembl chr17:25,461,633...25,475,338

G

BRCA1 associated RING domain 1

decreases expression

propionaldehyde results in decreased expression of BARD1 mRNA

NCBI chr 1:71,066,694...71,142,300
Ensembl chr 1:71,066,657...71,142,305

G

BarH-like homeobox 1

increases expression

propionaldehyde results in increased expression of BARX1 mRNA

NCBI chr13:48,816,512...48,819,983
Ensembl chr13:48,816,474...48,819,983

G

basic leucine zipper transcription factor, ATF-like 2

increases expression

propionaldehyde results in increased expression of BATF2 mRNA

NCBI chr19:6,214,424...6,222,506
Ensembl chr19:6,191,013...6,222,506

G

basic leucine zipper transcription factor, ATF-like 3

increases expression

propionaldehyde results in increased expression of BATF3 mRNA

NCBI chr 1:190,830,611...190,841,140
Ensembl chr 1:190,830,044...190,841,142

G

cDNA sequence BC028528

increases expression

propionaldehyde results in increased expression of C1ORF54 mRNA

NCBI chr 3:95,789,665...95,800,186
Ensembl chr 3:95,791,266...95,799,317

G

BCL11 transcription factor A

increases expression

propionaldehyde results in increased expression of BCL11A mRNA

NCBI chr11:24,026,498...24,123,558
Ensembl chr11:24,028,056...24,124,123

G

B cell leukemia/lymphoma 2 related protein A1b

increases expression

propionaldehyde results in increased expression of BCL2A1 mRNA

NCBI chr 9:89,081,326...89,089,891
Ensembl chr 9:89,081,262...89,089,880

G

Bcl2-like 10

increases expression

propionaldehyde results in increased expression of BCL2L10 mRNA

NCBI chr 9:75,255,040...75,258,922
Ensembl chr 9:75,255,040...75,258,931

G

beta-carotene oxygenase 2

increases expression

propionaldehyde results in increased expression of BCO2 mRNA

NCBI chr 9:50,444,387...50,466,513
Ensembl chr 9:50,444,387...50,466,481

G

brain derived neurotrophic factor

increases expression

propionaldehyde results in increased expression of BDNF mRNA

NCBI chr 2:109,505,045...109,557,388
Ensembl chr 2:109,505,045...109,557,352

G

brain expressed X-linked 1

increases expression

propionaldehyde results in increased expression of BEX2 mRNA

NCBI chr X:135,114,721...135,116,262
Ensembl chr X:135,114,721...135,116,262

G

brain expressed X-linked 4

increases expression

propionaldehyde results in increased expression of BEX4 mRNA

NCBI chr X:135,039,745...135,041,192
Ensembl chr X:135,039,745...135,041,192

G

basic helix-loop-helix family, member e41

increases expression

propionaldehyde results in increased expression of BHLHE41 mRNA

NCBI chr 6:145,803,969...145,811,146
Ensembl chr 6:145,803,969...145,811,284

G

BRD4 interacting chromatin remodeling complex associated protein

decreases expression

propionaldehyde results in decreased expression of BICRA mRNA

NCBI chr 7:15,704,596...15,785,047
Ensembl chr 7:15,704,597...15,781,846

G

BCL2-interacting killer

increases expression

propionaldehyde results in increased expression of BIK mRNA

NCBI chr15:83,410,992...83,428,836
Ensembl chr15:83,411,063...83,428,835

G

baculoviral IAP repeat-containing 3

increases expression

propionaldehyde results in increased expression of BIRC3 mRNA

NCBI chr 9:7,848,698...7,873,199
Ensembl chr 9:7,848,700...7,873,187

G

baculoviral IAP repeat-containing 5

decreases expression

propionaldehyde results in decreased expression of BIRC5 mRNA

NCBI chr11:117,740,063...117,746,569
Ensembl chr11:117,740,077...117,746,569

G

Bloom syndrome, RecQ like helicase

decreases expression

propionaldehyde results in decreased expression of BLM mRNA

NCBI chr 7:80,104,839...80,184,896
Ensembl chr 7:80,104,481...80,184,867

G

bone morphogenetic protein 10

increases methylation

propionaldehyde results in increased methylation of BMP10 gene

NCBI chr 6:87,405,976...87,411,494
Ensembl chr 6:87,405,976...87,414,659

G

bone morphogenetic protein 6

decreases expression

propionaldehyde results in decreased expression of BMP6 mRNA

NCBI chr13:38,529,098...38,684,283
Ensembl chr13:38,529,083...38,684,278

G

bone morphogenetic protein 7

increases expression

propionaldehyde results in increased expression of BMP7 mRNA

NCBI chr 2:172,709,805...172,782,114
Ensembl chr 2:172,709,805...172,782,114

G

bone morphogenetic protein 8a

increases expression

propionaldehyde results in increased expression of BMP8A mRNA

NCBI chr 4:123,206,438...123,237,045
Ensembl chr 4:123,206,438...123,237,045

G

BMP-binding endothelial regulator

increases expression

propionaldehyde results in increased expression of BMPER mRNA

NCBI chr 9:23,134,372...23,396,511
Ensembl chr 9:23,134,372...23,396,496

G

breast cancer 1, early onset

decreases expression

propionaldehyde results in decreased expression of BRCA1 mRNA

NCBI chr11:101,379,587...101,442,808
Ensembl chr11:101,379,590...101,442,781

G

BRCA1 interacting protein C-terminal helicase 1

decreases expression

propionaldehyde results in decreased expression of BRIP1 mRNA

NCBI chr11:85,948,957...86,092,041
Ensembl chr11:85,948,964...86,092,019

G

bromodomain and PHD finger containing, 3

decreases expression

propionaldehyde results in decreased expression of BRPF3 mRNA

NCBI chr17:29,020,088...29,057,763
Ensembl chr17:29,020,064...29,058,923

G

BTB domain containing 17

increases expression

propionaldehyde results in increased expression of BTBD17 mRNA

NCBI chr11:114,681,495...114,692,738
Ensembl chr11:114,682,043...114,686,771

G

BTG anti-proliferation factor 2

increases expression

propionaldehyde results in increased expression of BTG2 mRNA

NCBI chr 1:134,002,603...134,006,893
Ensembl chr 1:134,002,908...134,006,858

G

BUB1, mitotic checkpoint serine/threonine kinase

decreases expression

propionaldehyde results in decreased expression of BUB1 mRNA

NCBI chr 2:127,642,117...127,673,790
Ensembl chr 2:127,643,036...127,673,785

G

BUB1B, mitotic checkpoint serine/threonine kinase

decreases expression

propionaldehyde results in decreased expression of BUB1B mRNA

NCBI chr 2:118,428,684...118,472,073
Ensembl chr 2:118,428,692...118,472,072

G

complement component 1, q subcomponent, beta polypeptide

decreases expression

propionaldehyde results in decreased expression of C1QB mRNA

NCBI chr 4:136,607,437...136,613,511
Ensembl chr 4:136,607,440...136,613,498

G

complement component 1, q subcomponent-like 4

increases expression

propionaldehyde results in increased expression of C1QL4 mRNA

NCBI chr15:98,981,967...98,988,555
Ensembl chr15:98,981,967...98,985,698

G

C1q and tumor necrosis factor related protein 5

decreases expression

propionaldehyde results in decreased expression of C1QTNF5 mRNA

NCBI chr 9:44,013,067...44,020,484
Ensembl chr 9:44,018,542...44,020,484

G

C1q and tumor necrosis factor related protein 6

decreases expression

propionaldehyde results in decreased expression of C1QTNF6 mRNA

NCBI chr15:78,407,546...78,416,370
Ensembl chr15:78,407,546...78,415,616

G

complement component 1, r subcomponent B

decreases expression

propionaldehyde results in decreased expression of C1R mRNA

NCBI chr 6:124,547,389...124,558,003
Ensembl chr 6:124,547,253...124,558,130

G

complement component 1, s subcomponent 1

decreases expression

propionaldehyde results in decreased expression of C1S mRNA

NCBI chr 6:124,507,303...124,519,340
Ensembl chr 6:124,507,304...124,519,318

G

complement C2

increases expression

propionaldehyde results in increased expression of C2 mRNA

NCBI chr17:35,081,578...35,101,076
Ensembl chr17:35,081,580...35,117,241

G

complement component 6

decreases expression

propionaldehyde results in decreased expression of C6 mRNA

NCBI chr15:4,756,550...4,833,527
Ensembl chr15:4,756,657...4,844,449

G

calcium binding protein 1

increases expression

propionaldehyde results in increased expression of CABP1 mRNA

NCBI chr 5:115,306,750...115,332,440
Ensembl chr 5:115,306,748...115,332,440

G

calcium channel, voltage-dependent, N type, alpha 1B subunit

decreases expression

propionaldehyde results in decreased expression of CACNA1B mRNA

NCBI chr 2:24,493,872...24,653,210
Ensembl chr 2:24,493,899...24,653,164

G

calcium channel, voltage-dependent, T type, alpha 1G subunit

increases expression

propionaldehyde results in increased expression of CACNA1G mRNA

NCBI chr11:94,299,217...94,365,226
Ensembl chr11:94,299,217...94,365,024

G

calcium channel, voltage-dependent, alpha 1I subunit

decreases expression

propionaldehyde results in decreased expression of CACNA1I mRNA

NCBI chr15:80,171,439...80,282,493
Ensembl chr15:80,171,439...80,282,480

G

calcium channel, voltage-dependent, alpha 2/delta subunit 2

increases expression

propionaldehyde results in increased expression of CACNA2D2 mRNA

NCBI chr 9:107,276,948...107,406,545
Ensembl chr 9:107,276,811...107,406,542

G

calcium channel, voltage-dependent, gamma subunit 4

decreases expression

propionaldehyde results in decreased expression of CACNG4 mRNA

NCBI chr11:107,623,183...107,685,532
Ensembl chr11:107,623,183...107,685,383

G

calcium channel, voltage-dependent, gamma subunit 7

increases expression

propionaldehyde results in increased expression of CACNG7 mRNA

NCBI chr 7:3,381,341...3,416,737
Ensembl chr 7:3,381,471...3,416,737

G

cell adhesion molecule 2

decreases expression

propionaldehyde results in decreased expression of CADM2 mRNA

NCBI chr16:66,452,302...67,417,825
Ensembl chr16:66,452,307...67,417,796

G

calcitonin/calcitonin-related polypeptide, alpha

increases expression

propionaldehyde results in increased expression of CALCA mRNA

NCBI chr 7:114,225,223...114,236,145
Ensembl chr 7:114,230,713...114,235,592

G

calcium homeostasis modulator 3

increases expression

propionaldehyde results in increased expression of CALHM3 mRNA

NCBI chr19:47,140,138...47,146,203
Ensembl chr19:47,140,048...47,146,203

G

calcium/calmodulin-dependent protein kinase II inhibitor 1

decreases expression

propionaldehyde results in decreased expression of CAMK2N1 mRNA

NCBI chr 4:138,182,459...138,187,437
Ensembl chr 4:138,181,625...138,187,434

G

CaM kinase-like vesicle-associated

increases expression

propionaldehyde results in increased expression of CAMKV mRNA

NCBI chr 9:107,813,097...107,826,882
Ensembl chr 9:107,812,873...107,826,890

G

cathelicidin antimicrobial peptide

decreases expression

propionaldehyde results in decreased expression of CAMP mRNA

NCBI chr 9:109,676,445...109,678,524
Ensembl chr 9:109,676,447...109,678,685

G

calmodulin binding transcription activator 1

increases expression

propionaldehyde results in increased expression of CAMTA1 mRNA

NCBI chr 4:151,143,980...151,946,225
Ensembl chr 4:151,143,982...151,946,333

G

capping actin protein, gelsolin like

increases expression

propionaldehyde results in increased expression of CAPG mRNA

NCBI chr 6:72,515,265...72,539,966
Ensembl chr 6:72,521,374...72,539,966

G

calpain 12

increases expression

propionaldehyde results in increased expression of CAPN12 mRNA

NCBI chr 7:28,580,890...28,593,010
Ensembl chr 7:28,580,847...28,592,988

G

calpain 3

increases expression

propionaldehyde results in increased expression of CAPN3 mRNA

NCBI chr 2:120,294,074...120,335,400
Ensembl chr 2:120,294,053...120,335,399

G

carbonic anhydrase 4

increases expression

propionaldehyde results in increased expression of CA4 mRNA

NCBI chr11:84,848,580...84,856,880
Ensembl chr11:84,848,612...84,856,870

G

carbonic anhydrase 9

decreases expression

propionaldehyde results in decreased expression of CA9 mRNA

PMID:25014914 PMID:26079696

NCBI chr 4:43,507,026...43,513,729
Ensembl chr 4:43,506,966...43,513,729

G

caspase recruitment domain family, member 9

increases expression

propionaldehyde results in increased expression of CARD9 mRNA

NCBI chr 2:26,242,199...26,250,957
Ensembl chr 2:26,242,188...26,250,930

G

cardiac mesoderm enhancer-associated non-coding RNA

decreases expression

propionaldehyde results in decreased expression of CARMN mRNA

NCBI chr18:61,778,947...61,798,481
Ensembl chr18:61,782,325...61,799,611

G

carnosine synthase 1

decreases expression

propionaldehyde results in decreased expression of CARNS1 mRNA

NCBI chr19:4,214,323...4,227,390
Ensembl chr19:4,214,323...4,225,478

G

cation channel sperm associated auxiliary subunit zeta

increases expression

propionaldehyde results in increased expression of CATSPERZ mRNA

NCBI chr19:6,899,794...6,902,748
Ensembl chr19:6,899,739...6,902,748

G

coiled-coil and C2 domain containing 2B

decreases expression

propionaldehyde results in decreased expression of CC2D2B mRNA

NCBI chr19:40,737,197...40,818,227
Ensembl chr19:40,737,197...40,816,187

G

collagen and calcium binding EGF domains 1

increases expression

propionaldehyde results in increased expression of CCBE1 mRNA

NCBI chr18:66,189,926...66,424,909
Ensembl chr18:66,178,373...66,435,812

G

coiled-coil domain containing 103

increases expression

propionaldehyde results in increased expression of DNAAF19 mRNA

NCBI chr11:102,772,050...102,776,042
Ensembl chr11:102,772,030...102,776,042

G

coiled-coil domain containing 113

increases expression

propionaldehyde results in increased expression of CFAP263 mRNA

NCBI chr 8:96,260,684...96,285,516
Ensembl chr 8:96,260,713...96,285,518

G

coiled-coil domain containing 121

decreases expression

propionaldehyde results in decreased expression of CCDC121 mRNA

NCBI chr 5:31,643,205...31,645,820
Ensembl chr 5:31,643,084...31,645,820

G

coiled-coil domain containing 146

increases expression

propionaldehyde results in increased expression of CCDC146 mRNA

NCBI chr 5:21,496,749...21,629,675
Ensembl chr 5:21,497,959...21,629,675

G

coiled-coil domain containing 148

increases expression

propionaldehyde results in increased expression of CCDC148 mRNA

NCBI chr 2:58,701,637...58,991,167
Ensembl chr 2:58,711,082...58,991,027

G

coiled-coil domain containing 15

decreases expression

propionaldehyde results in decreased expression of CCDC15 mRNA

NCBI chr 9:37,178,758...37,262,508
Ensembl chr 9:37,187,131...37,259,728

G

coiled-coil domain containing 153

increases expression

propionaldehyde results in increased expression of DRC12 mRNA

NCBI chr 9:44,151,961...44,158,240
Ensembl chr 9:44,151,973...44,158,603

G

coiled-coil domain containing 160

increases expression

propionaldehyde results in increased expression of CCDC160 mRNA

NCBI chr X:51,880,045...51,888,351
Ensembl chr X:51,880,077...51,888,345

G

coiled-coil domain containing 169

increases expression

propionaldehyde results in increased expression of CCDC169 mRNA

NCBI chr 3:55,044,760...55,082,671
Ensembl chr 3:55,044,760...55,080,356

G

coiled-coil domain containing 18

decreases expression

propionaldehyde results in decreased expression of CCDC18 mRNA

NCBI chr 5:108,280,583...108,388,378
Ensembl chr 5:108,280,741...108,381,494

G

coiled coil domain containing 28B

increases expression

propionaldehyde results in increased expression of CCDC28B mRNA

NCBI chr 4:129,513,067...129,517,820
Ensembl chr 4:129,513,067...129,517,740

G

coiled-coil domain containing 3

increases expression

propionaldehyde results in increased expression of CCDC3 mRNA

NCBI chr 2:5,142,587...5,235,682
Ensembl chr 2:5,142,587...5,235,689

G

coiled-coil domain containing 30

increases expression

propionaldehyde results in increased expression of CCDC30 mRNA

NCBI chr 4:119,179,665...119,272,718
Ensembl chr 4:119,179,663...119,272,718

G

cholecystokinin

increases expression

propionaldehyde results in increased expression of CCK mRNA

NCBI chr 9:121,318,890...121,324,728
Ensembl chr 9:121,318,890...121,324,760

G

C-C motif chemokine ligand 2

increases expression

propionaldehyde results in increased expression of CCL2 mRNA

NCBI chr11:81,926,403...81,928,278
Ensembl chr11:81,926,397...81,928,279

G

C-C motif chemokine ligand 20

increases expression

propionaldehyde results in increased expression of CCL20 mRNA

NCBI chr 1:83,094,487...83,096,888
Ensembl chr 1:83,094,487...83,096,888

G

C-C motif chemokine ligand 21 (serine)

decreases expression

propionaldehyde results in decreased expression of CCL21 mRNA

NCBI chr 4:42,772,860...42,773,991
Ensembl chr 4:42,772,860...42,773,993

G

C-C motif chemokine ligand 26

increases expression

propionaldehyde results in increased expression of CCL26 mRNA

NCBI chr 5:135,589,302...135,592,423
Ensembl chr 5:135,589,302...135,592,423

G

C-C motif chemokine ligand 3

increases expression

propionaldehyde results in increased expression of CCL3 mRNA

NCBI chr11:83,538,669...83,540,204
Ensembl chr11:83,538,670...83,540,181

G

C-C motif chemokine ligand 5

increases expression

propionaldehyde results in increased expression of CCL5 mRNA

NCBI chr11:83,416,604...83,421,344
Ensembl chr11:83,416,604...83,421,344

G

C-C motif chemokine ligand 7

increases expression

propionaldehyde results in increased expression of CCL7 mRNA

NCBI chr11:81,936,538...81,938,351
Ensembl chr11:81,936,538...81,938,351

G

cerebral cavernous malformation 2-like

increases expression

propionaldehyde results in increased expression of CCM2L mRNA

NCBI chr 2:152,907,857...152,923,655
Ensembl chr 2:152,907,875...152,923,655

G

cellular communication network factor 3

increases expression

propionaldehyde results in increased expression of CCN3 mRNA

NCBI chr15:54,609,306...54,617,158
Ensembl chr15:54,609,098...54,617,435

G

cellular communication network factor 5

increases expression

propionaldehyde results in increased expression of CCN5 mRNA

NCBI chr 2:163,662,724...163,675,066
Ensembl chr 2:163,662,781...163,675,066

G

cyclin A1

increases methylation

propionaldehyde results in increased methylation of CCNA1 gene

NCBI chr 3:54,952,890...54,965,055
Ensembl chr 3:54,952,890...54,962,922

G

cyclin A2

decreases expression

propionaldehyde results in decreased expression of CCNA2 mRNA

NCBI chr 3:36,619,014...36,627,187
Ensembl chr 3:36,619,014...36,626,299

G

cyclin B1

decreases expression

propionaldehyde results in decreased expression of CCNB1 mRNA

NCBI chr13:100,915,247...100,922,994
Ensembl chr13:100,915,158...100,923,078

G

cyclin B1 interacting protein 1

increases methylation

propionaldehyde results in increased methylation of CCNB1IP1 gene

NCBI chr14:51,026,706...51,033,185
Ensembl chr14:51,026,705...51,045,189

G

cyclin B2

decreases expression

propionaldehyde results in decreased expression of CCNB2 mRNA

NCBI chr 9:70,314,971...70,328,836
Ensembl chr 9:70,314,974...70,328,829

G

cyclin D2

increases expression

propionaldehyde results in increased expression of CCND2 mRNA

NCBI chr 6:127,102,125...127,131,913
Ensembl chr 6:127,102,125...127,129,156

G

cyclin E2

decreases expression

propionaldehyde results in decreased expression of CCNE2 mRNA

NCBI chr 4:11,190,489...11,204,781
Ensembl chr 4:11,191,351...11,204,779

G

cyclin F

decreases expression

propionaldehyde results in decreased expression of CCNF mRNA

NCBI chr17:24,441,518...24,470,333
Ensembl chr17:24,441,172...24,470,458

G

CD22 antigen

increases expression

propionaldehyde results in increased expression of CD22 mRNA

NCBI chr 7:30,564,829...30,579,767
Ensembl chr 7:30,564,827...30,579,767

G

CD33 molecule

increases expression

propionaldehyde results in increased expression of CD33 mRNA

NCBI chr 7:43,176,823...43,186,679
Ensembl chr 7:43,173,640...43,193,852

G

CD40 antigen

increases expression

propionaldehyde results in increased expression of CD40 mRNA

NCBI chr 2:164,897,535...164,913,574
Ensembl chr 2:164,897,547...164,914,868

G

CD47 antigen (Rh-related antigen, integrin-associated signal transducer)

increases expression

propionaldehyde results in increased expression of CD47 mRNA

NCBI chr16:49,671,691...49,732,799
Ensembl chr16:49,620,896...49,735,373

G

CD52 antigen

increases expression

propionaldehyde results in increased expression of CD52 mRNA

NCBI chr 4:133,820,849...133,822,384
Ensembl chr 4:133,809,759...133,822,393

G

CD55 molecule, decay accelerating factor for complement

increases expression

propionaldehyde results in increased expression of CD55 mRNA

NCBI chr 1:130,357,526...130,390,513
Ensembl chr 1:130,366,764...130,390,481

G

CD68 antigen

increases expression

propionaldehyde results in increased expression of CD68 mRNA

NCBI chr11:69,555,039...69,556,996
Ensembl chr11:69,555,039...69,556,979

G

CD70 antigen

increases expression

propionaldehyde results in increased expression of CD70 mRNA

NCBI chr17:57,452,997...57,456,777
Ensembl chr17:57,452,997...57,456,777

G

CD79B antigen

increases expression

propionaldehyde results in increased expression of CD79B mRNA

NCBI chr11:106,202,167...106,205,388
Ensembl chr11:106,202,167...106,205,588

G

CD82 antigen

increases expression

propionaldehyde results in increased expression of CD82 mRNA

NCBI chr 2:93,249,447...93,293,295
Ensembl chr 2:93,249,456...93,293,485

G

CD83 antigen

increases expression

propionaldehyde results in increased expression of CD83 mRNA

NCBI chr13:43,938,661...43,956,608
Ensembl chr13:43,938,251...43,956,608

G

CD8 subunit alpha

increases expression

propionaldehyde results in increased expression of CD8A mRNA

NCBI chr 6:71,350,411...71,356,155
Ensembl chr 6:71,350,411...71,356,157

G

cell division cycle 20

decreases expression

propionaldehyde results in decreased expression of CDC20 mRNA

NCBI chr 4:118,290,098...118,294,540
Ensembl chr 4:118,290,098...118,294,549

G

cell division cycle 25C

decreases expression

propionaldehyde results in decreased expression of CDC25C mRNA

NCBI chr18:34,866,046...34,884,644
Ensembl chr18:34,866,046...34,884,586

G

CDC42 binding protein kinase gamma

increases expression

propionaldehyde results in increased expression of CDC42BPG mRNA

NCBI chr19:6,356,465...6,375,682
Ensembl chr19:6,356,486...6,375,682

G

cell division cycle 45

decreases expression

propionaldehyde results in decreased expression of CDC45 mRNA

NCBI chr16:18,599,202...18,632,371
Ensembl chr16:18,599,197...18,630,737

G

cell division cycle associated 3

decreases expression

propionaldehyde results in decreased expression of CDCA3 mRNA

NCBI chr 6:124,806,533...124,810,664
Ensembl chr 6:124,806,510...124,810,664

G

cell division cycle associated 5

decreases expression

propionaldehyde results in decreased expression of CDCA5 mRNA

NCBI chr19:6,135,127...6,141,803
Ensembl chr19:6,135,013...6,141,807

G

cell division cycle associated 8

decreases expression

propionaldehyde results in decreased expression of CDCA8 mRNA

NCBI chr 4:124,812,258...124,830,710
Ensembl chr 4:124,812,258...124,833,104

G

CUB domain containing protein 1

increases expression

propionaldehyde results in increased expression of CDCP1 mRNA

NCBI chr 9:122,999,870...123,045,175
Ensembl chr 9:122,999,889...123,045,103

G

cadherin 15

increases expression

propionaldehyde results in increased expression of CDH15 mRNA

NCBI chr 8:123,575,113...123,594,136
Ensembl chr 8:123,574,705...123,594,136

G

cadherin 16

decreases expression

propionaldehyde results in decreased expression of CDH16 mRNA

NCBI chr 8:105,328,547...105,351,028
Ensembl chr 8:105,328,543...105,351,028

G

cadherin related 23 (otocadherin)

increases expression

propionaldehyde results in increased expression of CDH23 mRNA

NCBI chr10:60,138,527...60,532,291
Ensembl chr10:60,138,527...60,532,269

G

cell death inducing Trp53 target 1

increases expression

propionaldehyde results in increased expression of CDIP1 mRNA

NCBI chr16:4,583,325...4,608,156
Ensembl chr16:4,568,212...4,608,156

G

CDIP transferase, opposite strand

increases expression

propionaldehyde results in increased expression of CDIPTOSP mRNA

NCBI chr 7:126,571,792...126,575,575
Ensembl chr 7:126,570,894...126,575,270

G

cyclin dependent kinase 1

decreases expression

propionaldehyde results in decreased expression of CDK1 mRNA

NCBI chr10:69,170,976...69,188,742
Ensembl chr10:69,170,976...69,188,768

G

cyclin dependent kinase 10

decreases expression

propionaldehyde results in decreased expression of CDK10 mRNA

NCBI chr 8:123,951,580...123,958,995
Ensembl chr 8:123,951,581...123,958,989

G

cyclin dependent kinase 2

decreases expression

propionaldehyde results in decreased expression of CDK2 mRNA

NCBI chr10:128,533,807...128,540,920
Ensembl chr10:128,533,808...128,540,900

G

cyclin dependent kinase inhibitor 2C

decreases expression

propionaldehyde results in decreased expression of CDKN2C mRNA

NCBI chr 4:109,518,073...109,523,953
Ensembl chr 4:109,518,073...109,524,386

G

cerebral dopamine neurotrophic factor

increases expression

propionaldehyde results in increased expression of CDNF mRNA

NCBI chr 2:3,514,102...3,527,413
Ensembl chr 2:3,514,067...3,527,413

G

CDP-diacylglycerol synthase 1

increases expression

propionaldehyde results in increased expression of CDS1 mRNA

NCBI chr 5:101,913,001...101,971,724
Ensembl chr 5:101,912,996...101,971,724

G

chromatin licensing and DNA replication factor 1

decreases expression

propionaldehyde results in decreased expression of CDT1 mRNA

NCBI chr 8:123,294,754...123,299,869
Ensembl chr 8:123,294,754...123,300,293

G

chromodomain protein, Y chromosome-like 2

increases expression

propionaldehyde results in increased expression of CDYL2 mRNA

NCBI chr 8:117,295,462...117,459,730
Ensembl chr 8:117,301,139...117,459,730

G

CECR2, histone acetyl-lysine reader

decreases expression

propionaldehyde results in decreased expression of CECR2 mRNA

NCBI chr 6:120,643,275...120,748,152
Ensembl chr 6:120,643,330...120,748,151

G

CUGBP, Elav-like family member 4

increases expression

propionaldehyde results in increased expression of CELF4 mRNA

NCBI chr18:25,610,677...25,887,577
Ensembl chr18:25,610,689...25,887,214

G

CUGBP, Elav-like family member 5

increases expression

propionaldehyde results in increased expression of CELF5 mRNA

NCBI chr10:81,295,061...81,318,564
Ensembl chr10:81,295,061...81,318,543

G

cell migration inducing protein, hyaluronan binding

increases expression

propionaldehyde results in increased expression of CEMIP mRNA

PMID:25014914 PMID:26079696

NCBI chr 7:83,582,065...83,735,893
Ensembl chr 7:83,582,065...83,735,710

G

cell cycle exit and neuronal differentiation 1

increases expression

propionaldehyde results in increased expression of CEND1 mRNA

NCBI chr 7:141,006,359...141,009,475
Ensembl chr 7:141,006,359...141,009,404

G

centromere protein A

decreases expression

propionaldehyde results in decreased expression of CENPA mRNA

NCBI chr 5:30,824,214...30,832,181
Ensembl chr 5:30,824,121...30,832,174

G

centromere protein E

decreases expression

propionaldehyde results in decreased expression of CENPE mRNA

NCBI chr 3:134,918,324...134,979,301
Ensembl chr 3:134,918,298...134,979,372

G

centromere protein F

decreases expression

propionaldehyde results in decreased expression of CENPF mRNA

NCBI chr 1:189,372,803...189,420,302
Ensembl chr 1:189,372,803...189,420,283

G

centromere protein H

decreases expression

propionaldehyde results in decreased expression of CENPH mRNA

NCBI chr13:100,896,187...100,912,415
Ensembl chr13:100,896,182...100,912,407

G

centromere protein I

decreases expression

propionaldehyde results in decreased expression of CENPI mRNA

NCBI chr X:133,206,777...133,263,853
Ensembl chr X:133,208,833...133,263,388

G

centromere protein J

decreases expression

propionaldehyde results in decreased expression of CPAP mRNA

NCBI chr14:56,764,218...56,812,950
Ensembl chr14:56,764,218...56,812,882

G

centromere protein K

decreases expression

propionaldehyde results in decreased expression of CENPK mRNA

NCBI chr13:104,365,474...104,386,130
Ensembl chr13:104,365,119...104,388,900

G

centromere protein N

decreases expression

propionaldehyde results in decreased expression of CENPN mRNA

NCBI chr 8:117,648,448...117,668,243
Ensembl chr 8:117,648,469...117,668,246

G

centromere protein O

decreases expression

propionaldehyde results in decreased expression of CENPO mRNA

NCBI chr12:4,243,548...4,284,255
Ensembl chr12:4,246,004...4,284,294

G

centromere protein P

decreases expression

propionaldehyde results in decreased expression of CENPP mRNA

NCBI chr13:49,617,501...49,806,457
Ensembl chr13:49,617,499...49,806,261

G

centrosomal protein 78

decreases expression

propionaldehyde results in decreased expression of CEP78 mRNA

NCBI chr19:15,933,134...15,962,396
Ensembl chr19:15,933,137...15,962,353

G

centrosomal protein 85

increases methylation

propionaldehyde results in increased methylation of CEP85 gene

NCBI chr 4:133,857,169...133,914,420
Ensembl chr 4:133,857,169...133,914,423

G

ceramide synthase 1

increases expression

propionaldehyde results in increased expression of CERS1 mRNA

NCBI chr 8:70,768,425...70,784,238
Ensembl chr 8:70,768,425...70,784,242

G

centrin 4

increases expression

propionaldehyde results in increased expression of CETN4P mRNA

NCBI chr 3:37,362,776...37,366,595
Ensembl chr 3:37,361,898...37,366,857

G

cilia and flagella associated protein 251

increases expression

propionaldehyde results in increased expression of CFAP251 mRNA

NCBI chr 5:123,390,196...123,465,547
Ensembl chr 5:123,390,165...123,465,547

G

cilia and flagella associated protein 300

increases expression

propionaldehyde results in increased expression of CFAP300 mRNA

NCBI chr 9:8,021,673...8,042,876
Ensembl chr 9:8,021,673...8,042,824

G

cilia and flagella associated protein 43

increases expression

propionaldehyde results in increased expression of CFAP43 mRNA

NCBI chr19:47,723,706...47,825,893
Ensembl chr19:47,725,296...47,907,726

G

cilia and flagella associated protein 52

increases expression

propionaldehyde results in increased expression of CFAP52 mRNA

NCBI chr11:67,815,632...67,856,494
Ensembl chr11:67,815,632...67,856,477

G

cilia and flagella associated protein 58

increases expression

propionaldehyde results in increased expression of CFAP58 mRNA

NCBI chr19:47,926,151...48,023,818
Ensembl chr19:47,926,114...48,023,826

G

cilia and flagella associated protein 70

increases expression

propionaldehyde results in increased expression of CFAP70 mRNA

NCBI chr14:20,444,258...20,502,332
Ensembl chr14:20,444,261...20,502,294

G

cilia and flagella associated protein 74

decreases expression

propionaldehyde results in decreased expression of CFAP74 mRNA

NCBI chr 4:155,493,647...155,551,280
Ensembl chr 4:155,493,647...155,551,280

G

cilia and flagella associated protein 92

increases expression

propionaldehyde results in increased expression of CFAP92 mRNA

NCBI chr 6:87,652,572...87,709,717
Ensembl chr 6:87,652,572...87,699,783

G

complement factor B

decreases expression

propionaldehyde results in decreased expression of CFB mRNA

NCBI chr17:35,075,350...35,081,492
Ensembl chr17:35,075,350...35,081,494

G

complement component factor i

decreases expression

propionaldehyde results in decreased expression of CFI mRNA

NCBI chr 3:129,630,432...129,668,978
Ensembl chr 3:129,629,533...129,668,981

G

glycoprotein hormones, alpha subunit

increases expression

propionaldehyde results in increased expression of CGA mRNA

NCBI chr 4:34,893,779...34,907,374
Ensembl chr 4:34,893,779...34,907,370

G

cingulin

increases expression

propionaldehyde results in increased expression of CGN mRNA

NCBI chr 3:94,667,376...94,695,036
Ensembl chr 3:94,667,376...94,693,826

G

cingulin-like 1

increases expression

propionaldehyde results in increased expression of CGNL1 mRNA

NCBI chr 9:71,533,789...71,716,582
Ensembl chr 9:71,533,791...71,678,884

G

ChaC, cation transport regulator 1

increases expression

propionaldehyde results in increased expression of CHAC1 mRNA

NCBI chr 2:119,181,723...119,184,807
Ensembl chr 2:119,181,710...119,184,862

G

coiled-coil-helix-coiled-coil-helix domain containing 10

increases expression

propionaldehyde results in increased expression of CHCHD10 mRNA

NCBI chr10:75,768,964...75,773,584
Ensembl chr10:75,768,964...75,773,581

G

chromodomain helicase DNA binding protein 3

decreases expression
increases methylation

propionaldehyde results in decreased expression of CHD3 mRNA
propionaldehyde results in increased methylation of CHD3 gene

PMID:26079696 PMID:30002397

NCBI chr11:69,234,099...69,260,325
Ensembl chr11:69,234,099...69,260,232

G

chromodomain helicase DNA binding protein 5

increases expression

propionaldehyde results in increased expression of CHD5 mRNA

NCBI chr 4:152,423,103...152,474,651
Ensembl chr 4:152,423,108...152,474,651

G

chitinase 1

decreases expression

propionaldehyde results in decreased expression of CHIT1 mRNA

NCBI chr 1:134,038,980...134,079,279
Ensembl chr 1:134,038,980...134,079,278

G

chromatin accessibility complex 1

decreases expression

propionaldehyde results in decreased expression of CHRAC1 mRNA

NCBI chr15:72,962,261...72,965,924
Ensembl chr15:72,962,241...72,969,403

G

chordin-like 2

decreases expression

propionaldehyde results in decreased expression of CHRDL2 mRNA

NCBI chr 7:99,655,611...99,683,935
Ensembl chr 7:99,655,379...99,683,935

G

cholinergic receptor, muscarinic 3, cardiac

increases expression

propionaldehyde results in increased expression of CHRM3 mRNA

NCBI chr13:9,925,522...10,411,131
Ensembl chr13:9,925,522...10,410,883

G

cholinergic receptor, nicotinic, alpha polypeptide 3

increases expression

propionaldehyde results in increased expression of CHRNA3 mRNA

NCBI chr 9:54,917,401...54,933,846
Ensembl chr 9:54,917,395...54,933,846

G

cholinergic receptor, nicotinic, alpha polypeptide 7

increases expression

propionaldehyde results in increased expression of CHRNA7 mRNA

NCBI chr 7:62,748,440...62,862,274
Ensembl chr 7:62,748,440...62,862,317

G

cholinergic receptor, nicotinic, beta polypeptide 4

decreases expression

propionaldehyde results in decreased expression of CHRNB4 mRNA

NCBI chr 9:54,935,438...54,956,236
Ensembl chr 9:54,935,438...54,956,063

G

carbohydrate sulfotransferase 1

increases expression

propionaldehyde results in increased expression of CHST1 mRNA

NCBI chr 2:92,429,978...92,445,597
Ensembl chr 2:92,430,052...92,445,595

G

carbohydrate sulfotransferase 11

increases expression

propionaldehyde results in increased expression of CHST11 mRNA

NCBI chr10:82,820,274...83,031,738
Ensembl chr10:82,821,332...83,031,734

G

carbohydrate sulfotransferase 2

increases expression

propionaldehyde results in increased expression of CHST2 mRNA

NCBI chr 9:95,282,979...95,289,323
Ensembl chr 9:95,281,345...95,288,775

G

carbohydrate sulfotransferase 5

increases expression

propionaldehyde results in increased expression of CHST6 mRNA

NCBI chr 8:112,615,767...112,636,831
Ensembl chr 8:112,615,768...112,637,079

G

calcium and integrin binding family member 4

decreases expression

propionaldehyde results in decreased expression of CIB4 mRNA

NCBI chr 5:30,642,927...30,703,191
Ensembl chr 5:30,642,927...30,703,180

G

CBY1 interacting BAR domain containing 2

increases expression

propionaldehyde results in increased expression of CIBAR2 mRNA

NCBI chr 8:120,893,136...120,904,225
Ensembl chr 8:120,893,136...120,904,205

G

cell death-inducing DNA fragmentation factor, alpha subunit-like effector B

decreases expression

propionaldehyde results in decreased expression of CIDEB mRNA

NCBI chr14:55,991,509...55,995,881
Ensembl chr14:55,991,507...55,995,915

G

ciliary microtubule inner protein 6

increases expression

propionaldehyde results in increased expression of CIMIP6 mRNA

NCBI chr11:30,376,006...30,421,829
Ensembl chr11:30,376,006...30,421,827

G

cell proliferation regulating inhibitor of protein phosphatase 2A

decreases expression

propionaldehyde results in decreased expression of CIP2A mRNA

NCBI chr16:48,814,524...48,840,079
Ensembl chr16:48,814,548...48,840,072

G

citron

decreases expression

propionaldehyde results in decreased expression of CIT mRNA

NCBI chr 5:115,983,284...116,147,012
Ensembl chr 5:115,983,337...116,147,006

G

Cbp/p300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 1

increases expression

propionaldehyde results in increased expression of CITED1 mRNA

NCBI chr X:101,290,984...101,295,787
Ensembl chr X:101,290,987...101,295,787

G

Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 4

increases expression

propionaldehyde results in increased expression of CITED4 mRNA

NCBI chr 4:120,523,760...120,525,017
Ensembl chr 4:120,523,769...120,525,017

G

cytoskeleton associated protein 2-like

decreases expression

propionaldehyde results in decreased expression of CKAP2L mRNA

NCBI chr 2:129,110,130...129,139,148
Ensembl chr 2:129,110,130...129,139,132

G

creatine kinase, brain

increases expression

propionaldehyde results in increased expression of CKB mRNA

NCBI chr12:111,635,789...111,638,772
Ensembl chr12:111,635,795...111,638,772

G

CDC28 protein kinase 1b

decreases expression

propionaldehyde results in decreased expression of CKS1B mRNA

NCBI chr 3:89,322,779...89,325,598
Ensembl chr 3:89,322,779...89,325,690

G

chloride channel, voltage-sensitive 4

increases expression

propionaldehyde results in increased expression of CLCN4 mRNA

NCBI chr 7:7,285,308...7,303,837
Ensembl chr 7:7,285,308...7,303,850

G

claudin 22

decreases expression

propionaldehyde results in decreased expression of CLDN22 mRNA

NCBI chr 8:48,277,501...48,278,511
Ensembl chr 8:48,277,517...48,278,511

G

claudin 3

increases expression

propionaldehyde results in increased expression of CLDN3 mRNA

NCBI chr 5:135,015,068...135,016,330
Ensembl chr 5:135,015,068...135,016,326

G

claudin 4

increases expression
decreases expression

propionaldehyde results in increased expression of CLDN4 mRNA
propionaldehyde results in decreased expression of CLDN4 mRNA

NCBI chr 5:134,973,977...134,975,788
Ensembl chr 5:134,973,973...134,975,788

G

chloride intracellular channel 3

increases expression

propionaldehyde results in increased expression of CLIC3 mRNA

NCBI chr 2:25,346,855...25,348,789
Ensembl chr 2:25,346,850...25,348,788

G

CXADR-like membrane protein

increases expression

propionaldehyde results in increased expression of CLMP mRNA

NCBI chr 9:40,596,975...40,696,849
Ensembl chr 9:40,597,258...40,696,615

G

clarin 3

decreases expression

propionaldehyde results in decreased expression of CLRN3 mRNA

NCBI chr 7:135,113,185...135,130,383
Ensembl chr 7:135,113,195...135,130,383

G

collectrin, amino acid transport regulator

increases expression

propionaldehyde results in increased expression of CLTRN mRNA

NCBI chr X:162,873,183...162,901,855
Ensembl chr X:162,871,826...162,901,856

G

cornichon family AMPA receptor auxiliary protein 2

increases expression

propionaldehyde results in increased expression of CNIH2 mRNA

NCBI chr19:5,142,896...5,148,549
Ensembl chr19:5,142,896...5,148,549

G

cornichon family AMPA receptor auxiliary protein 3

increases expression

propionaldehyde results in increased expression of CNIH3 mRNA

NCBI chr 1:181,178,024...181,288,059
Ensembl chr 1:181,180,193...181,288,206

G

calponin 1

increases expression

propionaldehyde results in increased expression of CNN1 mRNA

NCBI chr 9:22,010,501...22,020,517
Ensembl chr 9:22,010,512...22,020,926

G

calponin 2

increases expression

propionaldehyde results in increased expression of CNN2 mRNA

NCBI chr10:79,824,434...79,831,234
Ensembl chr10:79,824,418...79,831,896

G

cordon-bleu WH2 repeat

increases expression

propionaldehyde results in increased expression of COBL mRNA

NCBI chr11:12,186,676...12,415,022
Ensembl chr11:12,186,608...12,414,960

G

collagen, type XIII, alpha 1

increases expression

propionaldehyde results in increased expression of COL13A1 mRNA

NCBI chr10:61,674,013...61,814,985
Ensembl chr10:61,674,015...61,814,887

G

collagen, type XVI, alpha 1

increases expression

propionaldehyde results in increased expression of COL16A1 mRNA

NCBI chr 4:129,941,638...129,993,070
Ensembl chr 4:129,941,633...129,993,076

G

collagen, type I, alpha 1

increases expression

propionaldehyde results in increased expression of COL1A1 mRNA

NCBI chr11:94,827,050...94,843,868
Ensembl chr11:94,827,050...94,843,868

G

collagen, type XXVI, alpha 1

decreases expression

propionaldehyde results in decreased expression of COL26A1 mRNA

NCBI chr 5:136,770,613...136,912,230
Ensembl chr 5:136,770,613...136,912,063

G

collagen, type XXVIII, alpha 1

increases expression

propionaldehyde results in increased expression of COL28A1 mRNA

NCBI chr 6:7,997,100...8,193,709
Ensembl chr 6:7,997,808...8,192,617

G

collagen, type V, alpha 1

increases expression

propionaldehyde results in increased expression of COL5A1 mRNA

NCBI chr 2:27,776,393...27,929,522
Ensembl chr 2:27,776,437...27,929,526

G

collagen, type VI, alpha 2

increases expression

propionaldehyde results in increased expression of COL6A2 mRNA

NCBI chr10:76,431,590...76,459,464
Ensembl chr10:76,431,596...76,459,464

G

collectin sub-family member 12

increases expression

propionaldehyde results in increased expression of COLEC12 mRNA

NCBI chr18:9,707,648...9,877,995
Ensembl chr18:9,707,595...9,882,644

G

coronin 6

increases expression

propionaldehyde results in increased expression of CORO6 mRNA

NCBI chr11:77,353,149...77,361,310
Ensembl chr11:77,353,237...77,361,310

G

coactosin like F-actin binding protein 1

increases expression

propionaldehyde results in increased expression of COTL1 mRNA

NCBI chr 8:120,535,953...120,567,318
Ensembl chr 8:120,535,961...120,567,283

G

cytochrome c oxidase assembly protein 17, copper chaperone

increases methylation

propionaldehyde results in increased methylation of COX17 gene

NCBI chr16:38,167,332...38,173,125
Ensembl chr16:38,167,353...38,182,659

G

cytochrome c oxidase subunit 6A2

decreases expression

propionaldehyde results in decreased expression of COX6A2 mRNA

NCBI chr 7:127,804,607...127,805,538
Ensembl chr 7:127,804,607...127,805,559

G

cytochrome c oxidase subunit 8C

increases expression

propionaldehyde results in increased expression of COX8C mRNA

NCBI chr12:102,865,565...102,866,793
Ensembl chr12:102,865,575...102,866,785

G

ceruloplasmin

decreases expression

propionaldehyde results in decreased expression of CP mRNA

NCBI chr 3:20,011,097...20,063,914
Ensembl chr 3:20,011,218...20,063,309

G

carboxypeptidase A4

increases expression

propionaldehyde results in increased expression of CPA4 mRNA

NCBI chr 6:30,568,368...30,592,417
Ensembl chr 6:30,568,368...30,592,417

G

complexin 2

decreases expression

propionaldehyde results in decreased expression of CPLX2 mRNA

NCBI chr13:54,455,447...54,531,736
Ensembl chr13:54,519,162...54,531,730

G

carboxypeptidase N, polypeptide 1

decreases expression

propionaldehyde results in decreased expression of CPN1 mRNA

NCBI chr19:43,944,746...43,974,990
Ensembl chr19:43,944,746...43,974,995

G

carboxypeptidase Q

decreases expression

propionaldehyde results in decreased expression of PGCP mRNA

NCBI chr15:33,083,275...33,594,698
Ensembl chr15:33,083,275...33,594,698

G

carnitine palmitoyltransferase 1c

increases expression

propionaldehyde results in increased expression of CPT1C mRNA

NCBI chr 7:44,607,907...44,624,304
Ensembl chr 7:44,608,796...44,624,275

G

carboxypeptidase X, M14 family member 2

decreases expression

propionaldehyde results in decreased expression of CPXM2 mRNA

NCBI chr 7:131,634,416...131,756,483
Ensembl chr 7:131,634,416...131,756,468

G

cellular retinoic acid binding protein I

increases expression

propionaldehyde results in increased expression of CRABP1 mRNA

NCBI chr 9:54,672,032...54,680,394
Ensembl chr 9:54,672,032...54,680,394

G

cellular retinoic acid binding protein II

increases expression

propionaldehyde results in increased expression of CRABP2 mRNA

NCBI chr 3:87,856,000...87,860,679
Ensembl chr 3:87,855,973...87,860,683

G

crumbs family member 1, photoreceptor morphogenesis associated

increases expression

propionaldehyde results in increased expression of CRB1 mRNA

NCBI chr 1:139,101,288...139,307,262
Ensembl chr 1:139,124,794...139,304,838

G

cAMP responsive element binding protein 3-like 3

increases expression

propionaldehyde results in increased expression of CREB3L3 mRNA

NCBI chr10:80,920,163...80,934,706
Ensembl chr10:80,920,158...80,934,708

G

CREB binding protein

decreases expression

propionaldehyde results in decreased expression of CREBBP mRNA

NCBI chr16:3,899,198...4,031,864
Ensembl chr16:3,899,192...4,031,861

G

corticotropin releasing hormone receptor 1

decreases expression

propionaldehyde results in decreased expression of CRHR1 mRNA

NCBI chr11:104,021,289...104,066,349
Ensembl chr11:104,023,681...104,066,349

G

cysteine rich protein 2

increases expression

propionaldehyde results in increased expression of CRIP2 mRNA

NCBI chr12:113,103,856...113,109,126
Ensembl chr12:113,103,856...113,109,126

G

cysteine-rich protein 3

increases expression

propionaldehyde results in increased expression of CRIP3 mRNA

NCBI chr17:46,735,058...46,742,706
Ensembl chr17:46,739,852...46,742,702

G

cytokine receptor-like factor 1

increases expression

propionaldehyde results in increased expression of CRLF1 mRNA

NCBI chr 8:70,945,798...70,956,728
Ensembl chr 8:70,945,808...70,956,731

G

cartilage acidic protein 1

increases expression

propionaldehyde results in increased expression of CRTAC1 mRNA

NCBI chr19:42,271,474...42,421,405
Ensembl chr19:42,256,726...42,420,224

G

cone-rod homeobox

decreases expression

propionaldehyde results in decreased expression of CRX mRNA

NCBI chr 7:15,599,872...15,613,880
Ensembl chr 7:15,599,872...15,613,893

G

crystallin beta-gamma domain containing 1

increases expression

propionaldehyde results in increased expression of CRYBG1 mRNA

NCBI chr10:43,826,303...44,024,824
Ensembl chr10:43,826,632...44,024,849

G

crystallin beta-gamma domain containing 2

increases expression

propionaldehyde results in increased expression of CRYBG2 mRNA

NCBI chr 4:133,788,042...133,819,815
Ensembl chr 4:133,788,126...133,819,815

G

crystallin, mu

increases expression

propionaldehyde results in increased expression of CRYM mRNA

NCBI chr 7:119,785,603...119,801,212
Ensembl chr 7:119,785,603...119,801,334

G

colony stimulating factor 1 receptor

increases expression

propionaldehyde results in increased expression of CSF1R mRNA

NCBI chr18:61,238,644...61,264,211
Ensembl chr18:61,233,670...61,265,221

G

colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage)

increases expression

propionaldehyde results in increased expression of CSF2RA mRNA

NCBI chr19:61,205,629...61,221,141
Ensembl chr19:61,212,395...61,216,867

G

colony stimulating factor 3 (granulocyte)

increases expression

propionaldehyde results in increased expression of CSF3 mRNA

NCBI chr11:98,591,287...98,594,457
Ensembl chr11:98,592,089...98,594,455

G

cysteine and glycine-rich protein 1

increases expression

propionaldehyde results in increased expression of CSRP1 mRNA

NCBI chr 1:135,614,650...135,679,970
Ensembl chr 1:135,647,799...135,679,970

G

cystatin A family member 2

increases expression

propionaldehyde results in increased expression of CSTA mRNA

NCBI chr16:36,041,932...36,077,813
Ensembl chr16:36,041,838...36,077,810

G

CTD small phosphatase 1

decreases expression

propionaldehyde results in decreased expression of CTDSP1 mRNA

NCBI chr 1:74,430,625...74,436,444
Ensembl chr 1:74,430,668...74,436,444

G

collagen triple helix repeat containing 1

increases expression

propionaldehyde results in increased expression of CTHRC1 mRNA

NCBI chr15:38,940,327...38,950,516
Ensembl chr15:38,940,327...38,950,516

G

catenin delta 2

decreases expression

propionaldehyde results in decreased expression of CTNND2 mRNA

NCBI chr15:30,172,680...31,029,490
Ensembl chr15:30,172,739...31,029,487

G

cytidine 5'-triphosphate synthase 1

increases expression

propionaldehyde results in increased expression of CTPS1 mRNA

NCBI chr 4:120,397,065...120,427,473
Ensembl chr 4:120,397,065...120,427,473

G

cathepsin H

increases expression

propionaldehyde results in increased expression of CTSH mRNA

NCBI chr 9:89,936,320...89,958,148
Ensembl chr 9:89,936,205...89,958,142

G

C-X-C motif chemokine ligand 1

increases expression

propionaldehyde results in increased expression of CXCL1 mRNA

NCBI chr 5:91,039,104...91,040,980
Ensembl chr 5:91,039,100...91,040,974

G

C-X-C motif chemokine ligand 10

increases expression

propionaldehyde results in increased expression of CXCL10 mRNA

NCBI chr 5:92,494,497...92,496,748
Ensembl chr 5:92,494,497...92,496,748

G

C-X-C motif chemokine ligand 12

decreases expression

propionaldehyde results in decreased expression of CXCL12 mRNA

NCBI chr 6:117,145,496...117,158,329
Ensembl chr 6:117,145,496...117,158,328

G

C-X-C motif chemokine ligand 14

increases expression

propionaldehyde results in increased expression of CXCL14 mRNA

NCBI chr13:56,436,456...56,444,624
Ensembl chr13:56,436,456...56,444,364

G

C-X-C motif chemokine ligand 15

increases expression
increases secretion

propionaldehyde results in increased expression of CXCL8 mRNA
propionaldehyde results in increased secretion of CXCL8 protein

NCBI chr 5:90,942,393...90,950,926
Ensembl chr 5:90,942,393...90,950,926

G

C-X-C motif chemokine ligand 17

increases expression

propionaldehyde results in increased expression of CXCL17 mRNA

NCBI chr 7:25,099,478...25,112,311
Ensembl chr 7:25,099,478...25,112,311

G

C-X-C motif chemokine ligand 2

increases expression

propionaldehyde results in increased expression of CXCL2 mRNA

NCBI chr 5:91,051,758...91,053,797
Ensembl chr 5:91,051,730...91,053,797

G

C-X-C motif chemokine ligand 3

increases expression

propionaldehyde results in increased expression of CXCL1 mRNA

NCBI chr 5:90,933,960...90,935,952
Ensembl chr 5:90,933,962...90,937,459

G

C-X-C motif chemokine receptor 4

increases expression

propionaldehyde results in increased expression of CXCR4 mRNA

NCBI chr 1:128,515,936...128,520,036
Ensembl chr 1:128,515,936...128,520,030

G

cytochrome b-561

increases expression

propionaldehyde results in increased expression of CYB561 mRNA

NCBI chr11:105,824,528...105,844,157
Ensembl chr11:105,824,528...105,844,162

G

cytochrome b5 reductase 1

increases expression

propionaldehyde results in increased expression of CYB5R1 mRNA

NCBI chr 1:134,333,519...134,339,476
Ensembl chr 1:134,333,297...134,339,478

G

cytochrome b5 reductase 2

increases expression

propionaldehyde results in increased expression of CYB5R2 mRNA

NCBI chr 7:107,347,653...107,357,407
Ensembl chr 7:107,347,662...107,357,239

G

cytoplasmic FMR1 interacting protein 2

increases expression

propionaldehyde results in increased expression of CYFIP2 mRNA

NCBI chr11:46,084,676...46,203,686
Ensembl chr11:46,084,677...46,203,686

G

cytochrome P450, family 1, subfamily a, polypeptide 1

increases expression

propionaldehyde results in increased expression of CYP1A1 mRNA

PMID:25014914 PMID:26079696

NCBI chr 9:57,595,211...57,611,107
Ensembl chr 9:57,595,211...57,611,107

G

cytochrome P450, family 26, subfamily a, polypeptide 1

increases expression

propionaldehyde results in increased expression of CYP26A1 mRNA

NCBI chr19:37,686,186...37,689,984
Ensembl chr19:37,686,246...37,689,984

G

cytochrome P450, family 2, subfamily c, polypeptide 52, pseudogene

increases expression

propionaldehyde results in increased expression of CYP2C18 mRNA

NCBI chr19:38,965,106...38,992,071
Ensembl chr19:38,965,091...38,991,733

G

cytochrome P450, family 2, subfamily c, polypeptide 65

decreases expression

propionaldehyde results in decreased expression of CYP2C9 mRNA

NCBI chr19:39,049,450...39,082,392
Ensembl chr19:39,049,459...39,082,388

G

cytochrome P450, family 2, subfamily g, polypeptide 1

decreases expression

propionaldehyde results in decreased expression of CYP2G1P mRNA

NCBI chr 7:26,508,352...26,520,622
Ensembl chr 7:26,508,317...26,520,630

G

cytochrome P450, family 2, subfamily j, polypeptide 9

increases expression

propionaldehyde results in increased expression of CYP2J2 mRNA

NCBI chr 4:96,456,661...96,480,748
Ensembl chr 4:96,456,666...96,479,815

G

CYFIP related Rac1 interactor A

increases expression

propionaldehyde results in increased expression of CYRIA mRNA

NCBI chr12:12,312,136...12,430,966
Ensembl chr12:12,312,140...12,430,966

G

cysteine rich tail 1

increases expression

propionaldehyde results in increased expression of CYSRT1 mRNA

NCBI chr 2:25,128,831...25,129,876
Ensembl chr 2:25,128,830...25,132,464

G

cytohesin 4

increases expression

propionaldehyde results in increased expression of CYTH4 mRNA

NCBI chr15:78,481,247...78,506,219
Ensembl chr15:78,481,247...78,506,219

G

cytohesin 1 interacting protein

decreases expression

propionaldehyde results in decreased expression of CYTIP mRNA

NCBI chr 2:58,019,151...58,085,559
Ensembl chr 2:58,019,149...58,085,544

G

RIKEN cDNA D130043K22 gene

decreases expression

propionaldehyde results in decreased expression of KIAA0319 mRNA

NCBI chr13:25,029,114...25,085,422
Ensembl chr13:25,029,118...25,085,253

G

RIKEN cDNA D430041D05 gene

increases expression

propionaldehyde results in increased expression of KIAA1549L mRNA

NCBI chr 2:103,973,418...104,242,595
Ensembl chr 2:103,973,418...104,241,358

G

RIKEN cDNA D630039A03 gene

decreases expression

propionaldehyde results in decreased expression of C9ORF152 mRNA

NCBI chr 4:57,908,384...57,916,264
Ensembl chr 4:57,908,483...57,916,297

G

DNA segment, Chr 7, ERATO Doi 443, expressed

increases expression

propionaldehyde results in increased expression of C10ORF90 mRNA

NCBI chr 7:133,867,509...134,121,888
Ensembl chr 7:133,867,508...134,102,889

G

dishevelled-binding antagonist of beta-catenin 3

increases expression

propionaldehyde results in increased expression of DACT3 mRNA

NCBI chr 7:16,609,242...16,621,226
Ensembl chr 7:16,609,242...16,621,387

G

death associated protein-like 1

increases expression

propionaldehyde results in increased expression of DAPL1 mRNA

NCBI chr 2:59,314,997...59,335,364
Ensembl chr 2:59,314,997...59,335,364

G

dynein assembly factor with WDR repeat domains 1

increases expression

propionaldehyde results in increased expression of DAW1 mRNA

NCBI chr 1:83,136,610...83,188,298
Ensembl chr 1:83,137,473...83,188,295

G

discoidin, CUB and LCCL domain containing 2

increases expression

propionaldehyde results in increased expression of DCBLD2 mRNA

NCBI chr16:58,228,789...58,304,013
Ensembl chr16:58,228,806...58,290,090

G

doublecortin-like kinase 1

increases expression

propionaldehyde results in increased expression of DCLK1 mRNA

NCBI chr 3:55,149,724...55,446,489
Ensembl chr 3:55,149,785...55,446,489

G

DC-STAMP domain containing 2

decreases expression

propionaldehyde results in decreased expression of DCST2 mRNA

NCBI chr 3:89,257,724...89,284,950
Ensembl chr 3:89,269,282...89,284,856

G

dopa decarboxylase

decreases expression

propionaldehyde results in decreased expression of DDC mRNA

NCBI chr11:11,764,101...11,848,144
Ensembl chr11:11,764,101...11,848,144

G

D-aspartate oxidase

decreases expression

propionaldehyde results in decreased expression of DDO mRNA

NCBI chr10:40,505,933...40,557,847
Ensembl chr10:40,506,007...40,557,843

G

defensin beta 23

decreases expression

propionaldehyde results in decreased expression of DEFB129 mRNA

NCBI chr 2:152,300,914...152,306,540
Ensembl chr 2:152,300,975...152,306,540

G

DENN domain containing 1C

increases expression

propionaldehyde results in increased expression of DENND1C mRNA

NCBI chr17:57,373,051...57,385,518
Ensembl chr17:57,372,905...57,385,514

G

DENN domain containing 2C

increases expression

propionaldehyde results in increased expression of DENND2C mRNA

NCBI chr 3:103,009,954...103,077,054
Ensembl chr 3:103,009,920...103,077,085

G

DENN domain containing 2D

increases expression

propionaldehyde results in increased expression of DENND2D mRNA

NCBI chr 3:106,389,745...106,410,346
Ensembl chr 3:106,389,721...106,410,346

G

DEP domain containing 1a

decreases expression

propionaldehyde results in decreased expression of DEPDC1 mRNA

NCBI chr 3:159,201,042...159,235,690
Ensembl chr 3:159,201,070...159,235,592

G

DEP domain containing 1B

decreases expression

propionaldehyde results in decreased expression of DEPDC1B mRNA

NCBI chr13:108,452,592...108,526,100
Ensembl chr13:108,452,866...108,544,316

G

diacylglycerol kinase, alpha

increases expression

propionaldehyde results in increased expression of DGKA mRNA

NCBI chr10:128,556,000...128,581,002
Ensembl chr10:128,556,003...128,580,724

G

dihydrodiol dehydrogenase

increases expression

propionaldehyde results in increased expression of DHDH mRNA

NCBI chr 7:45,122,380...45,138,312
Ensembl chr 7:45,120,411...45,138,229

G

dihydrofolate reductase

decreases expression

propionaldehyde results in decreased expression of DHFR mRNA

NCBI chr13:92,491,291...92,525,561
Ensembl chr13:92,491,234...92,525,561

G

dehydrogenase/reductase member 2

increases expression

propionaldehyde results in increased expression of DHRS2 mRNA

NCBI chr14:55,459,464...55,478,897
Ensembl chr14:55,459,464...55,478,892

G

dehydrogenase/reductase 9

increases expression

propionaldehyde results in increased expression of DHRS9 mRNA

PMID:25014914 PMID:26079696

NCBI chr 2:69,210,806...69,233,430
Ensembl chr 2:69,210,789...69,234,877

G

DExH-box helicase 58

increases expression

propionaldehyde results in increased expression of DHX58 mRNA

NCBI chr11:100,585,710...100,595,165
Ensembl chr11:100,585,710...100,595,097

G

diaphanous related formin 3

decreases expression

propionaldehyde results in decreased expression of DIAPH3 mRNA

NCBI chr14:86,892,793...87,378,683
Ensembl chr14:86,892,803...87,378,671

G

divergent protein kinase domain 1B

increases expression

propionaldehyde results in increased expression of DIPK1B mRNA

NCBI chr 2:26,518,469...26,526,509
Ensembl chr 2:26,518,469...26,526,509

G

DIRAS family, GTP-binding RAS-like 1

increases expression

propionaldehyde results in increased expression of DIRAS1 mRNA

NCBI chr10:80,855,423...80,862,038
Ensembl chr10:80,855,423...80,861,496

G

disrupted in schizophrenia 1

increases expression

propionaldehyde results in increased expression of DISC1 mRNA

NCBI chr 8:125,773,928...125,991,882
Ensembl chr 8:125,780,934...125,988,597

G

dickkopf WNT signaling pathway inhibitor 3

increases expression

propionaldehyde results in increased expression of DKK3 mRNA

NCBI chr 7:111,715,226...111,758,689
Ensembl chr 7:111,715,224...111,758,264

G

DLG associated protein 5

decreases expression

propionaldehyde results in decreased expression of DLGAP5 mRNA

NCBI chr14:47,625,238...47,655,657
Ensembl chr14:47,625,236...47,655,864

G

delta like canonical Notch ligand 1

increases expression

propionaldehyde results in increased expression of DLL1 mRNA

NCBI chr17:15,587,616...15,597,275
Ensembl chr17:15,587,616...15,597,134

G

distal-less homeobox 2

increases expression

propionaldehyde results in increased expression of DLX2 mRNA

NCBI chr 2:71,373,752...71,377,095
Ensembl chr 2:71,373,752...71,377,098

G

dystrophin, muscular dystrophy

increases expression

propionaldehyde results in increased expression of DMD mRNA

NCBI chr X:81,858,244...84,248,656
Ensembl chr X:81,992,476...84,249,747

G

dermokine

increases expression

propionaldehyde results in increased expression of DMKN mRNA

NCBI chr 7:30,463,181...30,480,491
Ensembl chr 7:30,463,181...30,480,488

G

dynein axonemal assembly factor 11

increases expression

propionaldehyde results in increased expression of DNAAF11 mRNA

NCBI chr15:66,251,707...66,372,769
Ensembl chr15:66,251,707...66,372,759

G

dynein, axonemal assembly factor 2

increases methylation

propionaldehyde results in increased methylation of DNAAF2 gene

NCBI chr12:69,235,861...69,245,203
Ensembl chr12:69,235,861...69,245,203

G

dynein, axonemal assembly factor 3

increases expression

propionaldehyde results in increased expression of DNAAF3 mRNA

NCBI chr 7:4,525,932...4,535,487
Ensembl chr 7:4,525,932...4,535,452

G

dynein, axonemal, heavy chain 10

increases expression

propionaldehyde results in increased expression of DNAH10 mRNA

NCBI chr 5:124,802,149...124,911,372
Ensembl chr 5:124,802,149...124,911,372

G

dynein, axonemal, heavy chain 12

increases expression

propionaldehyde results in increased expression of DNAH12 mRNA

NCBI chr14:26,412,709...26,614,250
Ensembl chr14:26,414,429...26,613,660

G

dynein, axonemal, heavy chain 7B

increases expression

propionaldehyde results in increased expression of DNAH7 mRNA

NCBI chr 1:46,105,232...46,412,711
Ensembl chr 1:46,105,475...46,412,710

G

dynein axonemal intermediate chain 1

increases expression

propionaldehyde results in increased expression of DNAI1 mRNA

NCBI chr 4:41,569,731...41,638,158
Ensembl chr 4:41,569,775...41,638,158

G

dynein axonemal intermediate chain 3

increases expression

propionaldehyde results in increased expression of DNAI3 mRNA

NCBI chr 3:145,746,281...145,813,855
Ensembl chr 3:145,746,281...145,813,885

G

dynein axonemal intermediate chain 4

increases expression

propionaldehyde results in increased expression of DNAI4 mRNA

NCBI chr 4:102,891,954...102,971,524
Ensembl chr 4:102,895,262...102,971,752

G

dynein axonemal intermediate chain 7

increases expression

propionaldehyde results in increased expression of DNAI7 mRNA

NCBI chr 6:145,120,556...145,156,866
Ensembl chr 6:145,120,560...145,156,731

G

DnaJ heat shock protein family (Hsp40) member C5 beta

increases expression

propionaldehyde results in increased expression of DNAJC5B mRNA

NCBI chr 3:19,562,755...19,665,026
Ensembl chr 3:19,562,759...19,665,026

G

delta/notch-like EGF repeat containing

increases expression

propionaldehyde results in increased expression of DNER mRNA

NCBI chr 1:84,347,560...84,673,942
Ensembl chr 1:84,347,560...84,673,942

G

dynamin 3

increases expression

propionaldehyde results in increased expression of DNM3 mRNA

NCBI chr 1:161,810,022...162,305,890
Ensembl chr 1:161,810,022...162,305,603

G

dedicator of cytokinesis 4

increases expression

propionaldehyde results in increased expression of DOCK4 mRNA

NCBI chr12:40,495,956...40,896,873
Ensembl chr12:40,495,951...40,896,873

G

dedicator of cytokinesis 5

increases expression

propionaldehyde results in increased expression of DOCK5 mRNA

NCBI chr14:67,989,377...68,171,021
Ensembl chr14:67,989,584...68,170,891

G

dipeptidase 1

decreases expression

propionaldehyde results in decreased expression of DPEP1 mRNA

NCBI chr 8:123,913,069...123,928,551
Ensembl chr 8:123,912,981...123,928,551

G

dipeptidase 3

decreases expression

propionaldehyde results in decreased expression of DPEP3 mRNA

NCBI chr 8:106,700,152...106,706,051
Ensembl chr 8:106,700,145...106,706,061

G

dipeptidylpeptidase 4

increases expression

propionaldehyde results in increased expression of DPP4 mRNA

NCBI chr 2:62,160,417...62,242,635
Ensembl chr 2:62,160,417...62,242,575

G

dihydropyrimidine dehydrogenase

increases expression

propionaldehyde results in increased expression of DPYD mRNA

NCBI chr 3:118,355,758...119,226,573
Ensembl chr 3:118,355,778...119,226,573

G

dihydropyrimidinase-like 5

increases expression

propionaldehyde results in increased expression of DPYSL5 mRNA

NCBI chr 5:30,868,908...30,956,713
Ensembl chr 5:30,868,908...30,956,719

G

dopamine receptor D3

decreases expression

propionaldehyde results in decreased expression of DRD3 mRNA

NCBI chr16:43,574,285...43,646,353
Ensembl chr16:43,574,389...43,643,295

G

dorsal root ganglia homeobox

decreases expression

propionaldehyde results in decreased expression of DRGX mRNA

NCBI chr14:32,317,824...32,371,203
Ensembl chr14:32,321,364...32,371,203

G

DS cell adhesion molecule like 1

decreases expression

propionaldehyde results in decreased expression of DSCAML1 mRNA

NCBI chr 9:45,338,735...45,665,011
Ensembl chr 9:45,337,926...45,665,010

G

DNA replication and sister chromatid cohesion 1

decreases expression

propionaldehyde results in decreased expression of DSCC1 mRNA

NCBI chr15:54,939,497...54,953,887
Ensembl chr15:54,939,495...54,953,887

G

DSN1 homolog, MIS12 kinetochore complex component

decreases expression

propionaldehyde results in decreased expression of DSN1 mRNA

NCBI chr 2:156,836,982...156,848,995
Ensembl chr 2:156,837,185...156,849,074

G

deltex 1, E3 ubiquitin ligase

increases expression

propionaldehyde results in increased expression of DTX1 mRNA

NCBI chr 5:120,818,268...120,850,879
Ensembl chr 5:120,818,267...120,849,992

G

dual specificity phosphatase 1

increases expression

propionaldehyde results in increased expression of DUSP1 mRNA

NCBI chr17:26,724,565...26,727,446
Ensembl chr17:26,724,564...26,781,102

G

dual specificity phosphatase 26

increases expression

propionaldehyde results in increased expression of DUSP26 mRNA

NCBI chr 8:31,579,555...31,587,074
Ensembl chr 8:31,579,499...31,587,075

G

dual specificity phosphatase 6

increases expression

propionaldehyde results in increased expression of DUSP6 mRNA

NCBI chr10:99,098,676...99,103,351
Ensembl chr10:99,099,093...99,103,351

G

DPY30 domain containing 2

increases expression

propionaldehyde results in increased expression of DYDC2 mRNA

NCBI chr14:40,770,573...40,795,014
Ensembl chr14:40,771,074...40,791,165

G

E2F transcription factor 7

decreases expression

propionaldehyde results in decreased expression of E2F7 mRNA

NCBI chr10:110,580,799...110,623,245
Ensembl chr10:110,581,300...110,623,245

G

E2F transcription factor 8

decreases expression

propionaldehyde results in decreased expression of E2F8 mRNA

NCBI chr 7:48,516,177...48,531,821
Ensembl chr 7:48,516,177...48,531,344

G

Epstein-Barr virus induced gene 3

increases expression

propionaldehyde results in increased expression of EBI3 mRNA

NCBI chr17:56,259,623...56,264,022
Ensembl chr17:56,259,640...56,264,022

G

extracellular matrix protein 1

increases expression

propionaldehyde results in increased expression of ECM1 mRNA

NCBI chr 3:95,641,459...95,646,880
Ensembl chr 3:95,641,459...95,646,881

G

endothelin 2

increases expression

propionaldehyde results in increased expression of EDN2 mRNA

NCBI chr 4:120,018,403...120,024,557
Ensembl chr 4:120,018,403...120,024,557

G

endothelin 3

decreases expression

propionaldehyde results in decreased expression of EDN3 mRNA

NCBI chr 2:174,602,412...174,625,835
Ensembl chr 2:174,602,412...174,625,835

G

eukaryotic translation elongation factor 1 alpha 2

increases expression

propionaldehyde results in increased expression of EEF1A2 mRNA

NCBI chr 2:180,783,551...180,798,808
Ensembl chr 2:180,789,446...180,798,807

G

EF-hand calcium binding domain 10

increases expression

propionaldehyde results in increased expression of EFCAB10 mRNA

NCBI chr12:33,444,824...33,451,268
Ensembl chr12:33,444,853...33,451,266

G

EF-hand calcium binding domain 11

decreases expression

propionaldehyde results in decreased expression of EFCAB11 mRNA

NCBI chr12:99,683,790...99,849,701
Ensembl chr12:99,659,304...99,850,698

G

EF-hand calcium binding domain 2

decreases expression

propionaldehyde results in decreased expression of EFCAB2 mRNA

NCBI chr 1:178,233,583...178,312,078
Ensembl chr 1:178,233,650...178,312,078

G

epidermal growth factor-containing fibulin-like extracellular matrix protein 1

increases expression

propionaldehyde results in increased expression of EFEMP1 mRNA

NCBI chr11:28,803,154...28,876,743
Ensembl chr11:28,803,204...28,876,743

G

EF hand domain containing 1

increases expression

propionaldehyde results in increased expression of EFHD1 mRNA

NCBI chr 1:87,192,075...87,238,563
Ensembl chr 1:87,192,085...87,238,561

G

ephrin B2

increases expression

propionaldehyde results in increased expression of EFNB2 mRNA

NCBI chr 8:8,667,235...8,711,242
Ensembl chr 8:8,667,434...8,711,242

G

ephrin B3

increases expression

propionaldehyde results in increased expression of EFNB3 mRNA

NCBI chr11:69,444,918...69,452,428
Ensembl chr11:69,444,918...69,451,031

G

EFR3 homolog B

increases expression

propionaldehyde results in increased expression of EFR3B mRNA

NCBI chr12:4,012,554...4,089,199
Ensembl chr12:4,012,554...4,088,915

G

EGF-like and EMI domain containing 1

decreases expression

propionaldehyde results in decreased expression of EGFEM1P mRNA

NCBI chr 3:29,135,695...29,831,923
Ensembl chr 3:29,136,172...29,745,358

G

early growth response 2

increases expression

propionaldehyde results in increased expression of EGR2 mRNA

NCBI chr10:67,370,334...67,383,354
Ensembl chr10:67,371,305...67,378,018

G

endosome-lysosome associated apoptosis and autophagy regulator 1

increases expression

propionaldehyde results in increased expression of ELAPOR1 mRNA

NCBI chr 3:108,362,995...108,444,064
Ensembl chr 3:108,363,010...108,443,852

G

leucine rich repeat and fibronectin type III, extracellular 2

increases expression

propionaldehyde results in increased expression of ELFN2 mRNA

NCBI chr15:78,551,531...78,603,056
Ensembl chr15:78,551,531...78,602,971

G

ELMO/CED-12 domain containing 1

increases expression

propionaldehyde results in increased expression of ELMOD1 mRNA

NCBI chr 9:53,818,741...53,882,628
Ensembl chr 9:53,818,741...53,882,585

G

ELOVL fatty acid elongase 3

increases expression

propionaldehyde results in increased expression of ELOVL3 mRNA

NCBI chr19:46,120,336...46,124,133
Ensembl chr19:46,120,336...46,124,133

G

ELOVL fatty acid elongase 4

increases expression

propionaldehyde results in increased expression of ELOVL4 mRNA

NCBI chr 9:83,660,745...83,688,358
Ensembl chr 9:83,660,745...83,688,330

G

essential meiotic structure-specific endonuclease 1

decreases expression

propionaldehyde results in decreased expression of EME1 mRNA

NCBI chr11:94,535,798...94,544,611
Ensembl chr11:94,535,822...94,544,790

G

epithelial membrane protein 1

increases expression

propionaldehyde results in increased expression of EMP1 mRNA

NCBI chr 6:135,339,548...135,360,171
Ensembl chr 6:135,339,543...135,360,171

G

energy homeostasis associated

increases expression

propionaldehyde results in increased expression of ENHO mRNA

NCBI chr 4:41,638,144...41,640,302
Ensembl chr 4:41,638,144...41,640,324

G

enolase 2, gamma neuronal

increases expression

propionaldehyde results in increased expression of ENO2 mRNA

NCBI chr 6:124,737,018...124,746,489
Ensembl chr 6:124,737,016...124,746,636

G

enolase 3, beta muscle

increases expression

propionaldehyde results in increased expression of ENO3 mRNA

NCBI chr11:70,543,973...70,553,339
Ensembl chr11:70,548,028...70,553,339

G

ecto-NOX disulfide-thiol exchanger 1

increases expression

propionaldehyde results in increased expression of ENOX1 mRNA

NCBI chr14:77,393,790...77,959,203
Ensembl chr14:77,394,203...77,959,200

G

endosomal transmembrane epsin interactor 1

increases expression

propionaldehyde results in increased expression of ENTREP1 mRNA

NCBI chr19:23,950,114...24,008,800
Ensembl chr19:23,950,114...24,008,383

G

eomesodermin

increases expression

propionaldehyde results in increased expression of EOMES mRNA

NCBI chr 9:118,307,259...118,315,176
Ensembl chr 9:118,307,280...118,315,200

G

enhancer of polycomb homolog 2

decreases expression

propionaldehyde results in decreased expression of EPC2 mRNA

NCBI chr 2:49,341,498...49,441,954
Ensembl chr 2:49,341,498...49,441,960

G

exosomal polycystin 1 interacting protein

decreases expression

propionaldehyde results in decreased expression of EPCIP mRNA

NCBI chr16:90,841,534...90,866,040
Ensembl chr16:90,850,823...90,892,010

G

Eph receptor A10

increases expression

propionaldehyde results in increased expression of EPHA10 mRNA

NCBI chr 4:124,775,408...124,811,594
Ensembl chr 4:124,774,692...124,811,593

G

Eph receptor A2

increases expression

propionaldehyde results in increased expression of EPHA2 mRNA

NCBI chr 4:141,028,532...141,056,695
Ensembl chr 4:141,028,551...141,056,695

G

Eph receptor B2

increases expression

propionaldehyde results in increased expression of EPHB2 mRNA

NCBI chr 4:136,374,850...136,563,637
Ensembl chr 4:136,374,850...136,563,299

G

Eph receptor B3

increases expression

propionaldehyde results in increased expression of EPHB3 mRNA

NCBI chr16:21,023,530...21,042,054
Ensembl chr16:21,023,505...21,042,055

G

epsin 3

increases expression

propionaldehyde results in increased expression of EPN3 mRNA

NCBI chr11:94,380,425...94,390,800
Ensembl chr11:94,380,425...94,390,800

G

epiregulin

increases expression

propionaldehyde results in increased expression of EREG mRNA

NCBI chr 5:91,222,476...91,241,508
Ensembl chr 5:91,222,481...91,241,505

G

endoplasmic reticulum-golgi intermediate compartment 1

increases expression

propionaldehyde results in increased expression of ERGIC1 mRNA

NCBI chr17:26,779,736...26,875,908
Ensembl chr17:26,780,463...26,875,908

G

glutamate rich 4

decreases expression

propionaldehyde results in decreased expression of ERICH4 mRNA

NCBI chr 7:25,314,045...25,315,278
Ensembl chr 7:25,314,045...25,315,317

G

erythroblast membrane-associated protein

decreases expression

propionaldehyde results in decreased expression of ERMAP mRNA

NCBI chr 4:119,032,654...119,047,210
Ensembl chr 4:119,032,654...119,047,208

G

endoplasmic reticulum protein 27

decreases expression

propionaldehyde results in decreased expression of ERP27 mRNA

NCBI chr 6:136,884,312...136,899,465
Ensembl chr 6:136,884,309...136,899,178

G

endothelial cell-specific adhesion molecule

increases expression

propionaldehyde results in increased expression of ESAM mRNA

NCBI chr 9:37,439,385...37,449,615
Ensembl chr 9:37,439,374...37,449,615

G

establishment of sister chromatid cohesion N-acetyltransferase 2

decreases expression

propionaldehyde results in decreased expression of ESCO2 mRNA

NCBI chr14:66,056,476...66,071,418
Ensembl chr14:66,056,487...66,071,443

G

extra spindle pole bodies 1, separase

decreases expression

propionaldehyde results in decreased expression of ESPL1 mRNA

NCBI chr15:102,204,688...102,232,792
Ensembl chr15:102,204,701...102,232,792

G

ethanolamine kinase 2

increases expression

propionaldehyde results in increased expression of ETNK2 mRNA

NCBI chr 1:133,291,308...133,308,056
Ensembl chr 1:133,291,310...133,308,074

G

E26 avian leukemia oncogene 2, 3' domain

decreases expression

propionaldehyde results in decreased expression of ETS2 mRNA

NCBI chr16:95,503,274...95,522,093
Ensembl chr16:95,502,942...95,522,095

G

ecotropic viral integration site 5 like

increases expression

propionaldehyde results in increased expression of EVI5L mRNA

NCBI chr 8:4,216,523...4,258,089
Ensembl chr 8:4,216,567...4,261,257

G

exocyst complex component 3-like 4

increases expression

propionaldehyde results in increased expression of EXOC3L4 mRNA

NCBI chr12:111,383,864...111,398,114
Ensembl chr12:111,383,451...111,398,112

G

exosome component 8

decreases expression

propionaldehyde results in decreased expression of EXOSC8 mRNA

NCBI chr 3:54,636,099...54,642,469
Ensembl chr 3:54,636,099...54,642,814

G

exophilin 5

increases expression

propionaldehyde results in increased expression of EXPH5 mRNA

NCBI chr 9:53,212,814...53,292,466
Ensembl chr 9:53,212,970...53,288,814

G

coagulation factor XIII, beta subunit

decreases expression

propionaldehyde results in decreased expression of F13B mRNA

NCBI chr 1:139,429,285...139,451,496
Ensembl chr 1:139,429,440...139,451,490

G

coagulation factor II

decreases expression

propionaldehyde results in decreased expression of F2 mRNA

NCBI chr 2:91,442,742...91,466,799
Ensembl chr 2:91,455,665...91,466,759

G

coagulation factor II thrombin receptor

increases expression

propionaldehyde results in increased expression of F2R mRNA

NCBI chr13:95,738,288...95,754,974
Ensembl chr13:95,738,311...95,754,995

G

coagulation factor V

decreases expression

propionaldehyde results in decreased expression of F5 mRNA

NCBI chr 1:163,979,396...164,048,539
Ensembl chr 1:163,979,407...164,047,846

G

coagulation factor VII

decreases expression

propionaldehyde results in decreased expression of F7 mRNA

NCBI chr 8:13,075,499...13,085,809
Ensembl chr 8:13,076,034...13,085,809

G

fatty acid 2-hydroxylase

increases expression

propionaldehyde results in increased expression of FA2H mRNA

NCBI chr 8:112,071,770...112,120,453
Ensembl chr 8:112,071,767...112,120,456

G

Fanconi anemia core complex associated protein 24

decreases expression

propionaldehyde results in decreased expression of FAAP24 mRNA

NCBI chr 7:35,091,577...35,096,192
Ensembl chr 7:35,091,577...35,096,261

G

fatty acid binding protein 6

increases expression

propionaldehyde results in increased expression of FABP6 mRNA

NCBI chr11:43,486,867...43,492,389
Ensembl chr11:43,486,876...43,492,367

G

family with sequence similarity 110, member A

decreases expression

propionaldehyde results in decreased expression of FAM110A mRNA

NCBI chr 2:151,811,318...151,822,096
Ensembl chr 2:151,811,318...151,822,139

G

family with sequence similarity 13, member A

decreases expression

propionaldehyde results in decreased expression of FAM13A mRNA

NCBI chr 6:58,910,521...59,001,487
Ensembl chr 6:58,909,075...59,001,534

G

family with sequence similarity 184, member A

increases expression

propionaldehyde results in increased expression of FAM184A mRNA

NCBI chr10:53,509,131...53,627,368
Ensembl chr10:53,509,241...53,627,219

G

family with sequence similarity 25, member A

increases expression

propionaldehyde results in increased expression of FAM25A mRNA

NCBI chr14:34,073,842...34,080,296
Ensembl chr14:34,073,838...34,077,390

G

family with sequence similarity 43, member A

increases expression

propionaldehyde results in increased expression of FAM43A mRNA

NCBI chr16:30,418,541...30,421,615
Ensembl chr16:30,418,541...30,421,615

G

family with sequence similarity 43, member B

increases expression

propionaldehyde results in increased expression of FAM43B mRNA

NCBI chr 4:138,121,403...138,123,769
Ensembl chr 4:138,121,403...138,123,839

G

family with sequence similarity 90, member A1B

increases expression

propionaldehyde results in increased expression of FAM90A1 mRNA

NCBI chr  X:93,383,509...93,410,513
Ensembl chr  X:93,398,659...93,410,383
Ensembl chr  X:93,398,659...93,410,383

G

Fanconi anemia, complementation group D2

decreases expression

propionaldehyde results in decreased expression of FANCD2 mRNA

NCBI chr 6:113,508,622...113,573,981
Ensembl chr 6:113,508,643...113,573,978

G

Fanconi anemia, complementation group I

decreases expression

propionaldehyde results in decreased expression of FANCI mRNA

NCBI chr 7:79,042,056...79,100,013
Ensembl chr 7:79,041,677...79,100,012

G

Fas cell surface death receptor

increases expression

propionaldehyde results in increased expression of FAS mRNA

NCBI chr19:34,267,926...34,305,175
Ensembl chr19:34,268,066...34,305,172

G

Fas ligand

decreases expression

propionaldehyde results in decreased expression of FASLG mRNA

NCBI chr 1:161,608,260...161,616,064
Ensembl chr 1:161,608,258...161,616,064

G

filamin binding LIM protein 1

increases expression

propionaldehyde results in increased expression of FBLIM1 mRNA

NCBI chr 4:141,303,373...141,333,351
Ensembl chr 4:141,303,373...141,333,407

G

fibulin 2

increases expression

propionaldehyde results in increased expression of FBLN2 mRNA

NCBI chr 6:91,189,442...91,249,522
Ensembl chr 6:91,189,437...91,249,522

G

fibulin 5

increases expression

propionaldehyde results in increased expression of FBLN5 mRNA

NCBI chr12:101,712,820...101,785,541
Ensembl chr12:101,712,824...101,785,314

G

fibrillin 2

increases expression

propionaldehyde results in increased expression of FBN2 mRNA

NCBI chr18:58,141,689...58,343,200
Ensembl chr18:58,141,695...58,343,559

G

F-box protein 2

increases expression

propionaldehyde results in increased expression of FBXO2 mRNA

NCBI chr 4:148,244,605...148,250,874
Ensembl chr 4:148,245,078...148,250,881

G

F-box protein 24

decreases expression

propionaldehyde results in decreased expression of FBXO24 mRNA

NCBI chr 5:137,610,767...137,623,340
Ensembl chr 5:137,610,765...137,627,264

G

F-box protein 41

increases expression

propionaldehyde results in increased expression of FBXO41 mRNA

NCBI chr 6:85,446,556...85,479,976
Ensembl chr 6:85,446,556...85,479,976

G

F-box protein 43

decreases expression

propionaldehyde results in decreased expression of FBXO43 mRNA

NCBI chr15:36,150,206...36,170,086
Ensembl chr15:36,150,206...36,165,030

G

F-box protein 5

decreases expression

propionaldehyde results in decreased expression of FBXO5 mRNA

NCBI chr10:5,749,155...5,755,465
Ensembl chr10:5,749,160...5,755,600

G

F-box and WD-40 domain protein 13

decreases expression

propionaldehyde results in decreased expression of FBXW12 mRNA

NCBI chr 9:109,008,295...109,025,043
Ensembl chr 9:109,008,295...109,025,043

G

Fc receptor like 2

decreases expression

propionaldehyde results in decreased expression of FCRL2 mRNA

NCBI chr 3:87,158,318...87,171,046
Ensembl chr 3:87,158,065...87,171,045

G

ferredoxin reductase

increases expression

propionaldehyde results in increased expression of FDXR mRNA

NCBI chr11:115,158,850...115,167,925
Ensembl chr11:115,158,850...115,167,876

G

fer-1 like family member 6

decreases expression

propionaldehyde results in decreased expression of FER1L6 mRNA

NCBI chr15:58,381,897...58,536,936
Ensembl chr15:58,381,897...58,536,941

G

fasciculation and elongation protein zeta 1

increases expression

propionaldehyde results in increased expression of FEZ1 mRNA

NCBI chr 9:36,732,694...36,790,220
Ensembl chr 9:36,733,160...36,790,220

G

free fatty acid receptor 2

decreases expression

propionaldehyde results in decreased expression of FFAR2 mRNA

NCBI chr 7:30,517,778...30,523,200
Ensembl chr 7:30,517,773...30,523,200

G

fibrinogen alpha chain

decreases expression

propionaldehyde results in decreased expression of FGA mRNA

NCBI chr 3:82,933,460...82,940,934
Ensembl chr 3:82,933,383...82,940,934

G

fibrinogen beta chain

decreases expression

propionaldehyde results in decreased expression of FGB mRNA

NCBI chr 3:82,949,553...82,957,170
Ensembl chr 3:82,947,448...82,957,170

G

FYVE, RhoGEF and PH domain containing 3

increases expression

propionaldehyde results in increased expression of FGD3 mRNA

NCBI chr13:49,415,030...49,473,783
Ensembl chr13:49,415,030...49,473,787

G

fibroblast growth factor 13

increases expression

propionaldehyde results in increased expression of FGF13 mRNA

NCBI chr X:58,107,499...58,630,932
Ensembl chr X:58,107,505...58,613,431

G

fibroblast growth factor 20

increases expression

propionaldehyde results in increased expression of FGF20 mRNA

NCBI chr 8:40,732,206...40,740,060
Ensembl chr 8:40,732,207...40,761,372

G

fibroblast growth factor binding protein 1

increases expression

propionaldehyde results in increased expression of FGFBP1 mRNA

NCBI chr 5:44,136,200...44,139,173
Ensembl chr 5:44,136,200...44,139,121

G

fibroblast growth factor binding protein 3

increases expression

propionaldehyde results in increased expression of FGFBP3 mRNA

NCBI chr19:36,894,950...36,896,999
Ensembl chr19:36,894,950...36,897,015

G

fibrinogen gamma chain

decreases expression

propionaldehyde results in decreased expression of FGG mRNA

NCBI chr 3:82,915,031...82,922,363
Ensembl chr 3:82,915,031...82,922,356

G

fibrinogen-like protein 1

decreases expression

propionaldehyde results in decreased expression of FGL1 mRNA

NCBI chr 8:41,644,471...41,671,015
Ensembl chr 8:41,644,471...41,668,193

G

four and a half LIM domains 2

increases expression

propionaldehyde results in increased expression of FHL2 mRNA

NCBI chr 1:43,162,233...43,237,501
Ensembl chr 1:43,162,234...43,236,144

G

formin homology 2 domain containing 3

increases expression

propionaldehyde results in increased expression of FHOD3 mRNA

NCBI chr18:24,841,445...25,266,564
Ensembl chr18:24,841,680...25,266,558

G

fidgetin-like 1

decreases expression

propionaldehyde results in decreased expression of FIGNL1 mRNA

NCBI chr11:11,737,429...11,758,962
Ensembl chr11:11,737,431...11,758,962

G

FK506 binding protein 1b

increases expression

propionaldehyde results in increased expression of FKBP1B mRNA

NCBI chr12:4,883,174...4,891,736
Ensembl chr12:4,883,174...4,891,591

G

folliculin

increases expression

propionaldehyde results in increased expression of FLCN mRNA

NCBI chr11:59,682,234...59,706,138
Ensembl chr11:59,682,234...59,700,842

G

filamin, alpha

increases expression

propionaldehyde results in increased expression of FLNA mRNA

NCBI chr X:73,267,067...73,293,787
Ensembl chr X:73,267,067...73,293,426

G

FLYWCH-type zinc finger 1

increases expression

propionaldehyde results in increased expression of FLYWCH1 mRNA

NCBI chr17:23,971,767...23,993,504
Ensembl chr17:23,971,767...23,990,576

G

flavin containing monooxygenase 4

increases expression

propionaldehyde results in increased expression of FMO4 mRNA

NCBI chr 1:162,620,757...162,643,788
Ensembl chr 1:162,620,757...162,641,541

G

flavin containing monooxygenase 5

decreases expression

propionaldehyde results in decreased expression of FMO5 mRNA

NCBI chr 3:97,517,248...97,562,603
Ensembl chr 3:97,536,120...97,562,598

G

fibromodulin

increases expression

propionaldehyde results in increased expression of FMOD mRNA

NCBI chr 1:133,964,992...133,976,018
Ensembl chr 1:133,964,992...133,976,015

G

FMRP translational regulator 1, opposite strand

decreases expression

propionaldehyde results in decreased expression of FMR1-AS1 mRNA

NCBI chr X:67,711,120...67,722,005

G

fructosamine 3 kinase

decreases expression

propionaldehyde results in decreased expression of FN3K mRNA

NCBI chr11:121,325,779...121,341,316
Ensembl chr11:121,325,739...121,341,317

G

fibronectin type III domain containing 11

increases expression

propionaldehyde results in increased expression of FNDC11 mRNA

NCBI chr 2:180,854,385...180,864,649
Ensembl chr 2:180,861,806...180,864,647

G

fibronectin type III domain containing 3B

increases expression

propionaldehyde results in increased expression of FNDC3B mRNA

NCBI chr 3:27,470,284...27,765,469
Ensembl chr 3:27,470,311...27,765,456

G

fibronectin type III domain containing 5

increases expression

propionaldehyde results in increased expression of FNDC5 mRNA

NCBI chr 4:129,030,672...129,038,386
Ensembl chr 4:129,030,477...129,038,386

G

FBJ osteosarcoma oncogene

decreases expression

propionaldehyde results in decreased expression of FOS mRNA

NCBI chr12:85,520,664...85,524,048
Ensembl chr12:85,520,664...85,524,047

G

forkhead box M1

decreases expression

propionaldehyde results in decreased expression of FOXM1 mRNA

NCBI chr 6:128,339,957...128,352,849
Ensembl chr 6:128,339,930...128,353,109

G

forkhead box N4

increases expression

propionaldehyde results in increased expression of FOXN4 mRNA

NCBI chr 5:114,392,225...114,412,486
Ensembl chr 5:114,392,225...114,411,868

G

formyl peptide receptor 1

increases expression

propionaldehyde results in increased expression of FPR1 mRNA

NCBI chr17:18,096,733...18,104,201
Ensembl chr17:18,096,733...18,104,202

G

frequently rearranged in advanced T cell lymphomas

decreases expression

propionaldehyde results in decreased expression of FRAT1 mRNA

NCBI chr19:41,818,409...41,821,022
Ensembl chr19:41,818,409...41,821,022

G

FSHD region gene 2 family member 1

increases expression

propionaldehyde results in increased expression of FRG2B mRNA

NCBI chr 4:119,387,505...119,395,966
Ensembl chr 4:119,387,505...119,396,726

G

FERM domain containing 4B

decreases expression

propionaldehyde results in decreased expression of FRMD4B mRNA

NCBI chr 6:97,263,828...97,594,618
Ensembl chr 6:97,263,828...97,594,502

G

FERM domain containing 5

increases expression

propionaldehyde results in increased expression of FRMD5 mRNA

NCBI chr 2:121,376,010...121,637,580
Ensembl chr 2:121,376,010...121,637,568

G

FERM domain containing 8

increases expression

propionaldehyde results in increased expression of FRMD8 mRNA

NCBI chr19:5,901,002...5,925,297
Ensembl chr19:5,899,730...5,925,302

G

ferric-chelate reductase 1

increases expression

propionaldehyde results in increased expression of FRRS1 mRNA

NCBI chr 3:116,653,212...116,701,363
Ensembl chr 3:116,653,113...116,701,826

G

FRY microtubule binding protein

decreases expression

propionaldehyde results in decreased expression of FRY mRNA

NCBI chr 5:150,042,083...150,421,218
Ensembl chr 5:150,042,110...150,421,218

G

frizzled-related protein

increases expression

propionaldehyde results in increased expression of FRZB mRNA

NCBI chr 2:80,242,314...80,277,740
Ensembl chr 2:80,242,314...80,277,969

G

fascin actin-bundling protein 1

increases expression

propionaldehyde results in increased expression of FSCN1 mRNA

NCBI chr 5:142,946,110...142,958,944
Ensembl chr 5:142,946,098...142,958,940

G

follistatin-like 3

increases expression

propionaldehyde results in increased expression of FSTL3 mRNA

NCBI chr10:79,613,108...79,618,464
Ensembl chr10:79,613,106...79,618,464

G

follistatin-like 4

increases expression

propionaldehyde results in increased expression of FSTL4 mRNA

NCBI chr11:52,655,320...53,083,277
Ensembl chr11:52,655,461...53,079,365

G

formiminotransferase cyclodeaminase

increases expression

propionaldehyde results in increased expression of FTCD mRNA

NCBI chr10:76,411,482...76,426,172
Ensembl chr10:76,411,482...76,426,172

G

fucose mutarotase

increases expression

propionaldehyde results in increased expression of FUOM mRNA

NCBI chr 7:139,677,724...139,684,745
Ensembl chr 7:139,676,683...139,682,354

G

FXYD domain-containing ion transport regulator 2

decreases expression

propionaldehyde results in decreased expression of FXYD2 mRNA

NCBI chr 9:45,311,007...45,321,576
Ensembl chr 9:45,310,967...45,321,576

G

FXYD domain-containing ion transport regulator 7

increases expression

propionaldehyde results in increased expression of FXYD7 mRNA

NCBI chr 7:30,741,940...30,750,879
Ensembl chr 7:30,741,938...30,750,892

G

Fyn proto-oncogene

increases expression

propionaldehyde results in increased expression of FYN mRNA

NCBI chr10:39,245,735...39,441,377
Ensembl chr10:39,244,851...39,441,377

G

growth factor receptor bound protein 2-associated protein 3

increases expression

propionaldehyde results in increased expression of GAB3 mRNA

NCBI chr X:74,032,151...74,128,511
Ensembl chr X:74,010,449...74,129,064

G

gamma-aminobutyric acid type B receptor subunit 2

increases expression

propionaldehyde results in increased expression of GABBR2 mRNA

NCBI chr 4:46,662,318...46,991,714
Ensembl chr 4:46,662,305...46,991,873

G

glutamate decarboxylase 1

increases expression

propionaldehyde results in increased expression of GAD1 mRNA

NCBI chr 2:70,392,109...70,432,358
Ensembl chr 2:70,383,416...70,432,358

G

growth arrest and DNA-damage-inducible 45 alpha

increases expression

propionaldehyde results in increased expression of GADD45A mRNA

NCBI chr 6:67,012,080...67,014,391
Ensembl chr 6:67,012,080...67,014,441

G

growth arrest and DNA-damage-inducible 45 gamma

increases expression

propionaldehyde results in increased expression of GADD45G mRNA

NCBI chr13:52,000,711...52,002,511
Ensembl chr13:52,000,714...52,002,504

G

galanin and GMAP prepropeptide

increases expression

propionaldehyde results in increased expression of GAL mRNA

NCBI chr19:3,459,915...3,464,544
Ensembl chr19:3,459,915...3,464,544

G

galactose-3-O-sulfotransferase 1

decreases expression

propionaldehyde results in decreased expression of GAL3ST1 mRNA

NCBI chr11:3,933,636...3,949,328
Ensembl chr11:3,933,636...3,949,326

G

polypeptide N-acetylgalactosaminyltransferase 10

increases expression

propionaldehyde results in increased expression of GALNT10 mRNA

NCBI chr11:57,536,268...57,678,327
Ensembl chr11:57,536,268...57,678,340

G

polypeptide N-acetylgalactosaminyltransferase 16

increases expression

propionaldehyde results in increased expression of GALNT16 mRNA

NCBI chr12:80,565,245...80,650,672
Ensembl chr12:80,565,051...80,677,746

G

polypeptide N-acetylgalactosaminyltransferase 18

increases expression

propionaldehyde results in increased expression of GALNT18 mRNA

NCBI chr 7:111,070,863...111,379,274
Ensembl chr 7:111,070,868...111,379,184

G

polypeptide N-acetylgalactosaminyltransferase 5

increases expression

propionaldehyde results in increased expression of GALNT5 mRNA

NCBI chr 2:57,887,832...57,931,039
Ensembl chr 2:57,887,896...57,935,872

G

polypeptide N-acetylgalactosaminyltransferase 6

increases expression

propionaldehyde results in increased expression of GALNT6 mRNA

NCBI chr15:100,587,796...100,627,257
Ensembl chr15:100,589,694...100,627,257

G

UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase-like 6

decreases expression

propionaldehyde results in decreased expression of GALNTL6 mRNA

NCBI chr 8:58,225,523...59,366,213
Ensembl chr 8:58,227,086...59,365,674

G

guanidinoacetate methyltransferase

increases expression

propionaldehyde results in increased expression of GAMT mRNA

NCBI chr10:80,093,985...80,096,846
Ensembl chr10:80,093,985...80,096,846

G

golgi associated RAB2 interactor 1B

increases expression

propionaldehyde results in increased expression of GARIN1B mRNA

NCBI chr 6:29,313,468...29,336,021
Ensembl chr 6:29,319,139...29,336,018

G

GTPase activating RANGAP domain-like 3

increases expression

propionaldehyde results in increased expression of GARNL3 mRNA

NCBI chr 2:32,876,237...33,021,871
Ensembl chr 2:32,876,236...33,021,666

G

growth arrest-specific 2 like 3

decreases expression

propionaldehyde results in decreased expression of GAS2L3 mRNA

NCBI chr10:89,244,684...89,279,935
Ensembl chr10:89,244,685...89,279,829

G

GATA binding protein 5

increases expression

propionaldehyde results in increased expression of GATA5 mRNA

NCBI chr 2:179,966,881...179,977,296
Ensembl chr 2:179,966,926...179,976,492

G

guanylate binding protein 2b

increases expression

propionaldehyde results in increased expression of GBP1 mRNA

NCBI chr 3:142,300,577...142,324,940
Ensembl chr 3:142,300,608...142,324,940

G

gastrulation brain homeobox 2

increases expression

propionaldehyde results in increased expression of GBX2 mRNA

NCBI chr 1:89,855,684...89,858,898
Ensembl chr 1:89,855,678...89,858,901

G

glucagon receptor

increases expression

propionaldehyde results in increased expression of GCGR mRNA

NCBI chr11:120,420,011...120,429,815
Ensembl chr11:120,421,525...120,429,812

G

glucokinase regulatory protein

decreases expression

propionaldehyde results in decreased expression of GCKR mRNA

NCBI chr 5:31,454,594...31,484,646
Ensembl chr 5:31,454,787...31,484,658

G

glutamate-cysteine ligase, catalytic subunit

decreases expression

propionaldehyde results in decreased expression of GCLC mRNA

NCBI chr 9:77,661,817...77,701,771
Ensembl chr 9:77,661,817...77,701,767

G

glucosaminyl (N-acetyl) transferase 1, core 2

increases expression

propionaldehyde results in increased expression of GCNT1 mRNA

NCBI chr19:17,303,505...17,350,208
Ensembl chr19:17,303,505...17,350,208

G

growth differentiation factor 11

increases expression

propionaldehyde results in increased expression of GDF11 mRNA

NCBI chr10:128,716,393...128,727,587
Ensembl chr10:128,718,164...128,727,587

G

growth differentiation factor 15

increases expression

propionaldehyde results in increased expression of GDF15 mRNA

NCBI chr 8:71,082,043...71,085,106
Ensembl chr 8:71,082,043...71,085,106

G

glycerophosphodiester phosphodiesterase domain containing 1

increases expression

propionaldehyde results in increased expression of GDPD1 mRNA

NCBI chr11:86,924,620...86,964,963
Ensembl chr11:86,924,693...86,964,888

G

growth factor independent 1 transcription repressor

increases expression

propionaldehyde results in increased expression of GFI1 mRNA

NCBI chr 5:107,864,521...107,873,671
Ensembl chr 5:107,864,523...107,873,902

G

glucose-fructose oxidoreductase domain containing 1

increases expression

propionaldehyde results in increased expression of GFOD1 mRNA

NCBI chr13:43,348,716...43,457,648
Ensembl chr13:43,348,721...43,457,648

G

glial cell line derived neurotrophic factor family receptor alpha 1

increases expression

propionaldehyde results in increased expression of GFRA1 mRNA

NCBI chr19:58,224,013...58,444,387
Ensembl chr19:58,224,036...58,444,341

G

glial cell line derived neurotrophic factor family receptor alpha 4

decreases expression

propionaldehyde results in decreased expression of GFRA4 mRNA

NCBI chr 2:130,881,552...130,885,008
Ensembl chr 2:130,881,552...130,885,008

G

GINS complex subunit 1

decreases expression

propionaldehyde results in decreased expression of GINS1 mRNA

NCBI chr 2:150,751,482...150,773,200
Ensembl chr 2:150,747,320...150,773,200

G

GINS complex subunit 2

decreases expression

propionaldehyde results in decreased expression of GINS2 mRNA

NCBI chr 8:121,308,005...121,315,814
Ensembl chr 8:121,305,372...121,316,043

G

gap junction protein, alpha 3

increases expression

propionaldehyde results in increased expression of GJA3 mRNA

NCBI chr14:57,271,917...57,295,487
Ensembl chr14:57,271,917...57,295,557

G

gap junction protein, beta 1

decreases expression

propionaldehyde results in decreased expression of GJB1 mRNA

NCBI chr X:100,419,982...100,429,235
Ensembl chr X:100,419,984...100,429,235

G

gap junction protein, beta 2

increases expression

propionaldehyde results in increased expression of GJB2 mRNA

NCBI chr14:57,336,059...57,342,159
Ensembl chr14:57,336,057...57,342,159

G

gap junction protein, beta 4

increases expression

propionaldehyde results in increased expression of GJB4 mRNA

NCBI chr 4:127,234,892...127,247,929
Ensembl chr 4:127,244,879...127,247,874

G

gap junction protein, beta 5

increases expression

propionaldehyde results in increased expression of GJB5 mRNA

NCBI chr 4:127,248,600...127,251,957
Ensembl chr 4:127,248,602...127,251,974

G

gap junction protein, delta 3

increases expression

propionaldehyde results in increased expression of GJD3 mRNA

NCBI chr11:98,870,773...98,873,846
Ensembl chr11:98,873,006...98,873,842

G

gastrokine 1

increases expression

propionaldehyde results in increased expression of GKN1 mRNA

NCBI chr 6:87,322,635...87,327,897
Ensembl chr 6:87,322,632...87,327,924

G

gastrokine 2

increases expression

propionaldehyde results in increased expression of GKN2 mRNA

NCBI chr 6:87,350,347...87,356,476
Ensembl chr 6:87,350,339...87,356,479

G

glycine decarboxylase

increases expression

propionaldehyde results in increased expression of GLDC mRNA

NCBI chr19:30,075,847...30,152,829
Ensembl chr19:30,075,847...30,152,829

G

GLI pathogenesis related 1

increases expression

propionaldehyde results in increased expression of GLIPR1 mRNA

NCBI chr10:111,821,353...111,838,539
Ensembl chr10:111,821,353...111,838,536

G

GLI pathogenesis-related 2

increases expression

propionaldehyde results in increased expression of GLIPR2 mRNA

NCBI chr 4:43,957,702...43,979,118
Ensembl chr 4:43,957,401...43,979,118

G

glycerate kinase

decreases expression

propionaldehyde results in decreased expression of GLYCTK mRNA

NCBI chr 9:106,030,058...106,037,353
Ensembl chr 9:106,030,056...106,035,337

G

predicted gene 13889

increases expression

propionaldehyde results in increased expression of C11ORF96 mRNA

NCBI chr 2:93,786,155...93,787,445
Ensembl chr 2:93,786,155...93,787,546

G

predicted gene, 22728

decreases expression

propionaldehyde results in decreased expression of SCARNA23 mRNA

NCBI chr 5:92,203,923...92,204,051
Ensembl chr 5:92,203,923...92,204,051

G

predicted gene, 26871

increases expression

propionaldehyde results in increased expression of MIR137HG mRNA

NCBI chr 3:118,223,583...118,337,636
Ensembl chr 3:118,223,745...118,328,662

G

GM2 ganglioside activator protein

increases expression

propionaldehyde results in increased expression of GM2A mRNA

NCBI chr11:54,988,811...55,003,855
Ensembl chr11:54,988,941...55,003,855

G

predicted gene, 32687

increases expression

propionaldehyde results in increased expression of ZNF284 mRNA

NCBI chr10:81,699,690...81,716,920
Ensembl chr10:81,699,768...81,716,915

G

predicted gene 3443

decreases methylation

propionaldehyde results in decreased methylation of C9ORF57 gene

NCBI chr19:21,529,597...21,535,231
Ensembl chr19:21,530,305...21,535,021

G

predicted gene, 36566

increases expression

propionaldehyde results in increased expression of KLLN mRNA

NCBI chr19:32,731,847...32,734,812

G

predicted gene 3764

increases expression

propionaldehyde results in increased expression of MIR9-1HG mRNA

NCBI chr 3:88,113,980...88,137,266
Ensembl chr 3:88,113,033...88,137,271

G

predicted gene, 38656

increases expression

propionaldehyde results in increased expression of SCGB1D2 mRNA

NCBI chr19:9,162,589...9,164,383

G

predicted gene 572

decreases expression

propionaldehyde results in decreased expression of C1ORF127 mRNA

NCBI chr 4:148,727,774...148,761,562
Ensembl chr 4:148,727,774...148,760,753

G

predicted gene 6760

increases expression

propionaldehyde results in increased expression of SPANXN5 mRNA

NCBI chr X:63,195,011...63,195,804
Ensembl chr X:63,195,011...63,195,804

G

predicted gene 7030

increases expression

propionaldehyde results in increased expression of HLA-F mRNA

NCBI chr17:36,438,501...36,440,317
Ensembl chr17:36,420,611...36,440,317

G

predicted gene 7298

decreases expression

propionaldehyde results in decreased expression of CPAMD8 mRNA

NCBI chr 6:121,711,454...121,761,598
Ensembl chr 6:121,709,891...121,766,043

G

predicted gene 7694

increases expression

propionaldehyde results in increased expression of C1ORF226 mRNA

NCBI chr 1:170,125,767...170,133,901
Ensembl chr 1:170,125,768...170,133,901

G

guanosine monophosphate reductase

increases expression

propionaldehyde results in increased expression of GMPR mRNA

NCBI chr13:45,660,905...45,699,862
Ensembl chr13:45,660,920...45,707,276

G

guanine nucleotide binding protein, alpha O

increases expression

propionaldehyde results in increased expression of GNAO1 mRNA

NCBI chr 8:94,537,213...94,696,016
Ensembl chr 8:94,536,594...94,696,016

G

guanine nucleotide binding protein, alpha z subunit

increases expression

propionaldehyde results in increased expression of GNAZ mRNA

NCBI chr10:74,803,009...74,852,739
Ensembl chr10:74,803,009...74,852,739

G

guanine nucleotide binding protein (G protein), gamma 7

increases expression

propionaldehyde results in increased expression of GNG7 mRNA

NCBI chr10:80,784,463...80,850,742
Ensembl chr10:80,784,458...80,850,779

G

golgin A7B

increases expression

propionaldehyde results in increased expression of GOLGA7B mRNA

NCBI chr19:42,236,017...42,258,787
Ensembl chr19:42,236,013...42,258,787

G

G protein-coupled receptor 143

increases expression

propionaldehyde results in increased expression of GPR143 mRNA

NCBI chr X:151,564,917...151,591,647
Ensembl chr X:151,564,917...151,591,642

G

G protein-coupled receptor 146

decreases expression

propionaldehyde results in decreased expression of GPR146 mRNA

NCBI chr 5:139,363,452...139,382,170
Ensembl chr 5:139,363,452...139,382,170

G

G protein-coupled receptor 155

increases expression

propionaldehyde results in increased expression of GPR155 mRNA

NCBI chr 2:73,171,850...73,216,842
Ensembl chr 2:73,171,850...73,216,916

G

G protein-coupled receptor 160

increases expression

propionaldehyde results in increased expression of GPR160 mRNA

NCBI chr 3:30,909,908...30,951,344
Ensembl chr 3:30,910,099...30,951,341

G

G-protein coupled receptor 173

decreases expression

propionaldehyde results in decreased expression of GPR173 mRNA

NCBI chr X:151,126,594...151,151,763
Ensembl chr X:151,126,594...151,151,700

G

G protein-coupled receptor 20

increases expression

propionaldehyde results in increased expression of GPR20 mRNA

NCBI chr15:73,560,346...73,579,354
Ensembl chr15:73,566,453...73,579,354

G

G protein-coupled receptor 37-like 1

increases expression

propionaldehyde results in increased expression of GPR37L1 mRNA

NCBI chr 1:135,087,988...135,095,419
Ensembl chr 1:135,087,972...135,095,419

G

G protein-coupled receptor 87

increases expression

propionaldehyde results in increased expression of GPR87 mRNA

NCBI chr 3:59,086,325...59,102,583
Ensembl chr 3:59,086,344...59,102,525

G

G protein-coupled receptor, family C, group 5, member A

increases expression

propionaldehyde results in increased expression of GPRC5A mRNA

NCBI chr 6:135,042,660...135,061,707
Ensembl chr 6:135,042,649...135,061,707

G

glutathione peroxidase 1

increases expression

propionaldehyde results in increased expression of GPX1 mRNA

NCBI chr 9:108,216,279...108,217,541
Ensembl chr 9:108,216,102...108,217,542

G

glutathione peroxidase 2

decreases expression

propionaldehyde results in decreased expression of GPX2 mRNA

NCBI chr12:76,839,109...76,842,328
Ensembl chr12:76,839,107...76,842,273

G

GRAM domain containing 1C

increases expression

propionaldehyde results in increased expression of GRAMD1C mRNA

NCBI chr16:43,800,713...43,883,757
Ensembl chr16:43,800,713...43,883,708

G

GRAM domain containing 2B

increases expression

propionaldehyde results in increased expression of GRAMD2B mRNA

NCBI chr18:56,533,412...56,636,864
Ensembl chr18:56,533,409...56,636,864

G

growth regulation by estrogen in breast cancer-like

increases expression

propionaldehyde results in increased expression of GREB1L mRNA

NCBI chr18:10,324,933...10,562,945
Ensembl chr18:10,325,177...10,562,940

G

grainyhead like transcription factor 1

increases expression

propionaldehyde results in increased expression of GRHL1 mRNA

NCBI chr12:24,622,234...24,667,390
Ensembl chr12:24,622,282...24,667,390

G

grainyhead like transcription factor 3

increases expression

propionaldehyde results in increased expression of GRHL3 mRNA

NCBI chr 4:135,269,199...135,300,943
Ensembl chr 4:135,269,199...135,300,941

G

glutamate receptor, ionotropic, NMDA2C (epsilon 3)

increases expression

propionaldehyde results in increased expression of GRIN2C mRNA

NCBI chr11:115,139,995...115,158,123
Ensembl chr11:115,139,995...115,158,069

G

glutamate receptor, ionotropic, NMDA3B

increases expression

propionaldehyde results in increased expression of GRIN3B mRNA

NCBI chr10:79,806,227...79,813,024
Ensembl chr10:79,806,549...79,813,024

G

glutamate receptor, metabotropic 4

increases expression

propionaldehyde results in increased expression of GRM4 mRNA

NCBI chr17:27,641,361...27,732,800
Ensembl chr17:27,641,361...27,740,377

G

gastrin releasing peptide

increases expression

propionaldehyde results in increased expression of GRP mRNA

NCBI chr18:66,005,826...66,019,670
Ensembl chr18:66,005,891...66,019,667

G

glutathione S-transferase, alpha 1 (Ya)

decreases expression

propionaldehyde results in decreased expression of GSTA5 mRNA

NCBI chr 9:78,137,951...78,149,965
Ensembl chr 9:78,137,938...78,149,966

G

glutathione S-transferase, mu 5

increases expression

propionaldehyde results in increased expression of GSTM3 mRNA

NCBI chr 3:107,803,240...107,806,002
Ensembl chr 3:107,803,137...107,806,002

G

glutathione S-transferase omega 2

increases expression

propionaldehyde results in increased expression of GSTO2 mRNA

NCBI chr19:47,853,879...47,874,747
Ensembl chr19:47,853,973...47,874,763

G

GTF2I repeat domain containing 2

decreases expression

propionaldehyde results in decreased expression of GTF2IRD2 mRNA

NCBI chr 5:134,211,629...134,246,988
Ensembl chr 5:134,212,858...134,253,209

G

G two S phase expressed protein 1

decreases expression

propionaldehyde results in decreased expression of GTSE1 mRNA

NCBI chr15:85,743,928...85,760,774
Ensembl chr15:85,743,946...85,760,774

G

guanylate cyclase activator 2a (guanylin)

decreases expression

propionaldehyde results in decreased expression of GUCA2A mRNA

NCBI chr 4:119,494,929...119,496,662
Ensembl chr 4:119,494,901...119,496,668

G

guanylate cyclase 1, soluble, beta 1

increases expression

propionaldehyde results in increased expression of GUCY1B1 mRNA

NCBI chr 3:81,939,311...81,982,018
Ensembl chr 3:81,939,313...81,981,996

G

H19, imprinted maternally expressed transcript

decreases expression

propionaldehyde results in decreased expression of H19 mRNA

NCBI chr 7:142,129,267...142,131,883
Ensembl chr 7:142,129,262...142,133,957

G

H1.4 linker histone, cluster member

decreases expression

propionaldehyde results in decreased expression of H1-4 mRNA

NCBI chr13:23,805,760...23,806,541
Ensembl chr13:23,804,612...23,806,541

G

H1.8 linker histone

decreases expression

propionaldehyde results in decreased expression of H1-8 mRNA

NCBI chr 6:115,921,892...115,927,203
Ensembl chr 6:115,921,899...115,927,197

G

H1.9 linker histone

decreases expression

propionaldehyde results in decreased expression of H1-9P mRNA

NCBI chr11:94,858,419...94,859,282
Ensembl chr11:94,858,419...94,859,282

G

histocompatibility 2, class II antigen A, alpha

decreases expression

propionaldehyde results in decreased expression of HLA-DQA1 mRNA

NCBI chr17:34,501,718...34,506,797
Ensembl chr17:34,501,718...34,506,797

G

histocompatibility 2, M region locus 2

increases expression

propionaldehyde results in increased expression of HLA-B mRNA

NCBI chr17:37,791,742...37,794,445
Ensembl chr17:37,791,742...37,794,443

G

histocompatibility 2, O region alpha locus

increases expression

propionaldehyde results in increased expression of HLA-DOA mRNA

NCBI chr17:34,311,353...34,314,286
Ensembl chr17:34,311,314...34,314,208

G

H2A clustered histone 1

decreases expression

propionaldehyde results in decreased expression of H2AC1 mRNA

NCBI chr13:24,118,420...24,118,896
Ensembl chr13:24,118,445...24,118,834

G

H2A clustered histone 20

decreases expression

propionaldehyde results in decreased expression of H2AC20 mRNA

NCBI chr 3:96,127,728...96,128,209
Ensembl chr 3:96,127,677...96,128,196

G

H2A clustered histone 21

decreases expression

propionaldehyde results in decreased expression of H2AC21 mRNA

NCBI chr 3:96,127,201...96,127,634
Ensembl chr 3:96,127,181...96,127,624

G

H2A clustered histone 25

decreases expression

propionaldehyde results in decreased expression of H2AC25 mRNA

NCBI chr11:58,845,511...58,846,018
Ensembl chr11:58,845,511...58,847,656

G

H2A clustered histone 4

decreases expression

propionaldehyde results in decreased expression of H2AC4 mRNA

NCBI chr13:23,935,061...23,935,577
Ensembl chr13:23,935,109...23,935,581

G

H2B clustered histone 6

decreases expression
increases methylation

propionaldehyde results in decreased expression of H2BC6 mRNA
propionaldehyde results in increased methylation of H2BC6 gene

PMID:26079696 PMID:30002397

NCBI chr13:23,767,653...23,805,091
Ensembl chr13:23,767,653...23,805,107

G

H3 clustered histone 11

decreases expression

propionaldehyde results in decreased expression of H3C7 mRNA

NCBI chr13:21,967,085...21,967,567
Ensembl chr13:21,967,130...21,967,540

G

H3 clustered histone 7

decreases expression

propionaldehyde results in decreased expression of H3C15 mRNA

NCBI chr13:23,728,222...23,729,124
Ensembl chr13:23,728,222...23,729,482

G

H3 clustered histone 8

decreases expression

propionaldehyde results in decreased expression of H3C12 mRNA

NCBI chr13:23,719,588...23,720,079
Ensembl chr13:23,719,592...23,720,121

G

H4 clustered histone 1

decreases expression

propionaldehyde results in decreased expression of H4C1 mRNA

NCBI chr13:23,944,778...23,945,232
Ensembl chr13:23,944,675...23,945,213

G

H4 clustered histone 12

decreases expression

propionaldehyde results in decreased expression of H4C8 mRNA

NCBI chr13:21,934,315...21,934,723
Ensembl chr13:21,934,364...21,934,675

G

H4 clustered histone 18

decreases expression

propionaldehyde results in decreased expression of H4C13 mRNA

NCBI chr13:22,015,962...22,016,367
Ensembl chr13:22,015,937...22,016,366

G

H4 clustered histone 4

decreases expression

propionaldehyde results in decreased expression of H4C15 mRNA

NCBI chr13:23,765,551...23,765,952
Ensembl chr13:23,765,581...23,766,718

G

H4 clustered histone 8

decreases expression

propionaldehyde results in decreased expression of H4C9 mRNA

NCBI chr13:23,715,214...23,715,648
Ensembl chr13:23,715,220...23,715,689

G

hyaluronic acid binding protein 2

decreases expression

propionaldehyde results in decreased expression of HABP2 mRNA

NCBI chr19:56,275,541...56,309,252
Ensembl chr19:56,275,569...56,309,254

G

hydroxyacid oxidase 1, liver

decreases expression

propionaldehyde results in decreased expression of HAO1 mRNA

NCBI chr 2:134,339,281...134,396,272
Ensembl chr 2:134,339,281...134,396,288

G